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The efficacy of screening, brief, intervention, referral to treatment (SBIRT) in reducing 
or eliminating methamphetamine use has not been investigated and addressed among 
patients with heart failure. According to urine toxicology screens at admission at a county 
hospital, approximately 50% of patients in a heart failure program were positive for illicit 
substance use, and the majority of these tests (>60%) were for methamphetamine use, 
one of the most cardiotoxic drugs available. This quantitative study used an existing 
dataset to test the theory of intentional behavior by examining whether SBIRT 
intervention increases the patient’s ability to make a behavioral change and, therefore, 
makes a difference in rehospitalizations for patients with heart failure who screen positive 
for methamphetamine use. Three separate logistic regression tests compared which 
variables had the most influence across SBIRT or the severity of substance use on 30, 60, 
and 90 days of rehospitalizations while controlling for the patients who received 
screenings upon each hospital admission. The comparison between these 3 groups 
indicate a relationship between severity of methamphetamine use and having a 5-time 
increase in rehospitalization at 30 days. This project addresses an underresearched area 
for individuals with mild and moderate substance use problems with comorbid medical 
conditions. The findings may create positive social change for treatment providers by 
allowing them to understand that SBIRT is a general approach and not a specific 
technique. The results of this study may help health care providers such as doctors, 
nurses, and health educators and social workers to assist in patient substance use recovery 
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Chapter 1: Introduction to the Study 
The current study examined intentional behavior change that related to 
rehospitalizations based on the severity of methamphetamine abuse and receiving a 
screening, brief intervention, and referral to treatment (SBIRT) in the Heart Failure 
Program at a Santa Clara County hospital. Although I found literature on illicit substance 
use and SBIRT, heart failure, and rehospitalizations, I was unable to find research that 
explored the intersection of these ideas. This study has many potential social 
implications. Not only will the current research serve to fill a gap in the existing 
literature, but it will also illuminate the issue and the effect of SBIRT with mild to 
moderate use of methamphetamine use and rehospitalization within chronic patients with 
heart failure. This study is of importance to the field of social work practice as both 
hospitals and primary care are moving more toward integrated behavioral health and 
whole person care (Hansen et al., 2019). 
In Chapter 1, I discuss the background and scope of the study. I then describe the 
social problem and purpose of the study. I also introduce the research question along with 
details about the nature of the study. In Chapter 2, I conduct a review of the extant peer-
reviewed literature. I then present all relevant existing literature regarding the topic. In 
the third chapter, the methodology, I discuss my approach to this study. Chapters 4 and 5 
consist of the data analysis and findings of the research.  
Background 
The gap in the literature that this study addresses are the links between 




patients who have chronic health conditions, particularly those who have heart 
conditions. The scope of this study includes rehospitalizations and severity of 
methamphetamine use with patients who have chronic health conditions and 
rehospitalizations with use of SBIRT in patients with chronic health conditions, 
particularly heart failure. This study is important because it contributes to the field of 
physical and behavioral health and promotes an understanding of the effect of SBIRT 
with mild and moderate substance use problems and comorbid medical conditions. 
A vast number of physical ailments are associated with methamphetamine use, 
including stroke; heart attack; damage to liver, kidney, and lungs; injuries; and death 
(Darke et al., 2017). Methamphetamine use can also exacerbate several chronic medical 
conditions, including hypertension and heart failure (National Institute on Drug Abuse 
[NIDA], 2013; Stanford, 2009). When providers do not screen or assess for substance use 
and misuse, this can compromise medical treatment in numerous ways; for example, lack 
of screening can increase the risks for adverse drug interactions and hampering adherence 
to medications and other treatment protocols (Paratz et al., 2016). Some people do not 
know that their level of substance use is risky; education and feedback about the level of 
use may be enough to motivate change (Tarango & Baird, 2018). Research relating to 
SBIRT began more than 40 years ago, and multiple trials now provide evidence of 
SBIRT’s effectiveness. Meta-analyses and reviews that included more than 34 
randomized controlled trials of SBIRT (focused primarily on at-risk and problem 
drinkers) revealed an overall 10% to 30% reduction in alcohol consumption at 12 months 




Researchers have expanded their analysis of SBIRT to address illicit substances. 
Saitz et al. (2012) acknowledge that screening, brief intervention, referral to treatment 
(SBI) has been proven to be effective on unhealthy alcohol use, but there is a concern that 
drug SBI may have limited or no efficacy. This three-group randomized trial tested the 
efficacy of two brief counseling interventions for unhealthy drug use, a brief negotiated 
interview, and adaptation of motivational interviewing compared with no-brief 
intervention. Saitz et al. cautioned that brief intervention (BI) for drug use in primary care 
settings due to patients discussing drug use may cause challenges as health care providers 
struggle to determine between appropriate use and inappropriate use of illicit drugs. Saitz 
et al. reasoned for caution in using BI for drug use, provided that researchers examine 
different models of SBI that are economically sound and sustainable for those patients 
who were present with different levels of motivation for change. 
Roy-Byrne et al. (2014) researched whether BI improves drug use outcomes 
compared with care as usual. One group received a single BI using motivational 
interviewing, a handout, and a list of substance abuse resources, and a 10-minute 
telephone booster within 2 weeks (Roy-Byrne et al., 2014). The other group received care 
as usual, which included a handout and a list of substance abuse resources. The one-time 
BI with attempted telephone booster did not affect drug use patterns in primary care 
settings (Roy-Byrne et al., 2014). Although this study showed no effectiveness, this may 
have been due to participants receiving only a single BI. It is important to note that 




negotiated interview is unrealistic. It is relevant to this social issue to know that multiple 
sessions are often necessary (Roy-Byrne et al., 2014).  
The research expanded to explore the use of SBIRT for its suitable method of 
identification and intervention techniques for evidence of efficacy in reducing illicit 
substance use (Dwinnells, 2015). Dwinnells’ (2015) quasi-experimental study examined 
the effectiveness of the SBIRT at a community health center. The results suggest that in 
an outpatient clinic, SBIRT is effective in identifying patients at risk for depression, 
alcohol, and substance use. This study proved to affect the improvement of identification 
and diagnosis. Despite research indicating low efficacy of BI for drug use found through 
screening in the primary care setting, their studies have implications for the integration of 
behavioral health with specialty care where there are major unmet health needs such as 
chronic illnesses and substance abuse (Dwinnells, 2015; Saitz, 2014). Furthermore, there 
is a need to explore the modification in the use of SBIRT in specialty care clinics. 
Problem Statement 
The link between substance use disorders and physical health is well established. 
Patients who abuse alcohol and drugs are much more likely to develop medical problems 
than the general population (Schulte & Hser, 2014). These patients tend to present more 
frequently for medical conditions caused by or exacerbated by continued alcohol and 
drug use. According to the National Survey on Drug Use and Health, the Substance 
Abuse and Mental Health Services Administration (SAMHSA), reported that illicit drug 
use in the United States has been increasing (United Nations Office on Drugs and Crime 




prescription stimulants. Amphetamine is the most commonly used and misused drug 
second only to cannabis (UNODC, 2017). In California, 20- to 29-year-olds comprised 
34% of all individuals admitted to treatment for primary methamphetamine use, and it is 
the primary drug responsible for 26% of all hospital admissions (SAMHSA, 2011). 
Methamphetamine is one of the most cardiotoxic drugs and can cause numerous 
heart failure problems stemming from chronic drug-induced hypertension, tachycardia, 
and cardiac arrhythmia (Yeo et al., 2007). It is well-established that heart failure is an 
economic burden on the health care system (Diercks et al., 2008). Recognition of 
methamphetamine-associated cardiomyopathy among medical caregivers is important, 
given the growing use of methamphetamine. Methamphetamine use after heart surgery 
often counters the medical procedures and increases recidivism back to the hospital (Yeo 
et al., 2007). 
Even though methamphetamine-associated problems are recognized, there is 
rarely any intervention to reduce methamphetamine use and further complications 
(Zgierska et al., 2014). Several research studies demonstrate the effects of SBIRT on 
patient outcomes with chronic health conditions, including tobacco use and at-risk 
alcohol use with chronic health care conditions (Babor et al., 2007; Glass et al., 2017; 
Saitz et al., 2010; Saitz, 2014; Timko et al., 2016). 
A study by Swaminathan et al. (2014) examined the effects of screening, 
assessment, and BI on patients’ outcomes with chronic health conditions. This study 
illuminates important findings but, after a comprehensive empirical literature search, 




disorders and the efficacy on a target population such as patients with heart failure. Given 
such, further research is warranted that could examine the utility of BI for mild to 
moderate substance use disorders in an effort to address the documented problem that 
approximately 50% of patients with heart failure screened positive for methamphetamine 
use in a heart failure program at a Santa Clara County hospital (Swaminathan et al., 
2014). 
Purpose of the Study 
The purpose of this quantitative study using an existing dataset was to test the 
theory of intentional behavior change that relates to rehospitalizations based on severity 
of methamphetamine abuse using the CAGE-AID score and receiving a SBIRT in a heart 
failure program at a Santa Clara County hospital.  
Research Questions 
The research question for this study is as follows: Does the SBIRT intervention 
increase the patient’s ability to make a behavioral change and therefore make a difference 
in rehospitalizations for patients with heart failure who screen positive for 
methamphetamine use? 
Framework 
The theoretical base for this study was the transtheoretical model (TTM). 
According to DiClemente (2018), the process of intentional behavior change can be 
explained through the core dimensions of the TTM. The model’s initial insight stated that 
process change only happened in the framework of the stages of change. The TTM (also 




1970s, evolved through studies examining the experiences of smokers who quit on their 
own in relation to those requiring further treatment to understand why some people were 
capable of quitting on their own (Prochaska et al., 1992). It was determined that people 
quit smoking if they were ready to do so. Thus, the TTM focuses on the decision making 
of the individual and is a model of intentional change. The TTM operates on the 
assumption that people do not change behaviors quickly and decisively. Rather, change in 
behavior, especially habitual behavior, occurs continuously through a cyclical process. 
The TTM is not a theory but a model; different behavioral theories and constructs can be 
applied to various stages of the model where they may be most effective. 
The TTM posits that individuals move through six stages of change: 
precontemplation, contemplation, preparation, action, maintenance, and termination 
(Prochaska et al., 1992). Termination was not part of the original model and is less often 
used in application of stages of change for health-related behaviors. For each stage of 
change, different intervention strategies are most effective at moving the person to the 
next stage of change and subsequently through the model to maintenance, the ideal stage 
of behavior (Prochaska et al., 1992). 
Precontemplation: In this stage, people do not intend to take action in the 
foreseeable future (defined as within the next 6 months). People are often 
unaware that their behavior is problematic or produces negative consequences. 
People in this stage often underestimate the pros of changing behavior and place 




Contemplation: In this stage, people are intending to start the healthy behavior in 
the foreseeable future (defined as within the next 6 months). People recognize that 
their behavior may be problematic, and a more thoughtful and practical 
consideration of the pros and cons of changing the behavior takes place, with 
equal emphasis placed on both. Even with this recognition, people may still feel 
ambivalent toward changing their behavior. 
Preparation (determination): In this stage, people are ready to take action within 
the next 30 days. People start to take small steps toward the behavior change, and 
they believe changing their behavior can lead to a healthier life. 
Action: In this stage, people have recently changed their behavior (defined as 
within the last 6 months) and intend to keep moving forward with that behavior 
change. People may exhibit this by modifying their problem behavior or acquiring 
new healthy behaviors. 
Maintenance: In this stage, people have sustained their behavior change for a 
while (defined as more than 6 months) and intend to maintain the behavior change 
going forward. People in this stage work to prevent relapse to earlier stages. 
Termination: In this stage, people have no desire to return to their unhealthy 
behaviors and are sure they will not relapse. Since this is rarely reached, and 
people tend to stay in the maintenance stage, this stage is often not considered in 





To progress through the stages of change, people apply cognitive, affective, and 
evaluative processes. Ten processes of change have been identified, with some processes 
being more relevant to a specific stage of change than others (Prochaska et al., 1992). 
These processes result in strategies that help people make and maintain change. 
1. Consciousness raising: Increasing awareness about the healthy behavior. 
2. Dramatic relief: Emotional arousal about the health behavior, whether 
positive or negative arousal. 
3. Self-reevaluation: Self reappraisal to realize the healthy behavior is part of 
who they want to be. 
4. Environmental reevaluation: Social reappraisal to realize how their 
unhealthy behavior affects others. 
5. Social liberation: Environmental opportunities that exist to show society is 
supportive of the healthy behavior. 
6. Self-liberation: Commitment to change behavior based on the belief that 
achievement of the healthy behavior is possible. 
7. Helping relationships: Finding supportive relationships that encourage the 
desired change. 
8. Counter-conditioning: Substituting healthy behaviors and thoughts for 
unhealthy behaviors and thoughts. 
9. Reinforcement management: Rewarding the positive behavior and 
reducing the rewards that come from negative behavior. This is where 




10. Stimulus control: Re-engineering the environment to have reminders and 
cues that support and encourage the healthy behavior and remove those 
that encourage the unhealthy behavior. 
 
As DiClemente’s (2018) research progressed, it became evident that the process 
of change expanded. There are two types of processes of change involved in intentional 
behavior change. One type represents cognitive and experiential processes, which 
involves thinking and feeling, such as consciousness-raising: gaining information that 
increases awareness about the current behavior pattern or the potential for new behavior. 
The second type involves an action-oriented process that involves behavioral 
commitment and actions to create or break a habit such as reinforcement management: 
identifying and manipulating the positive and negative reinforcers for current or new 
behavior. Intentional behavior change requires creating rewards for new behaviors while 
eliminating reinforcements for current behaviors. 
Limitations of the TTM 
There are several limitations of TTM, which should be considered when using 
this theory in public health. Limitations of the model include the following: 
1. The theory ignores the social context in which change occurs, such as SES 
and income. 
2. The lines between the stages can be arbitrary with no set criteria of how to 




developed to assign a person to a stage of change are not always standardized 
or validated. 
3. There is no clear sense for how much time is needed for each stage, or how 
long a person can remain in a stage.  
Although the model assumes that individuals make coherent and logical plans in 
their decision-making process, this is not always true. 
The TTM provides suggested strategies for public health interventions to address 
people at various stages of the decision-making process. This can result in interventions 
that are tailored (i.e., a message or program component has been specifically created for a 
target population's level of knowledge and motivation) and effective. The TTM 
encourages an assessment of an individual’s current stage of change and accounts for 
relapse in people’s decision-making process. 
The TTM provides suggested strategies such as SBIRT for public health 
interventions to address intentional behavior change. The concept that makes the TTM 
unique is the idea that change occurs over time, an aspect overlooked by other theories of 
change (Prochaska et al., 1992). According to TTM, behavior change is treated as 
progressive and continuous rather than linear. Viewing behavior change as dynamic, 
nonlinear, and inherently complex is considered one of the theory’s strengths (Marshall 
& Biddle, 2001). DiClemente et al. (2004) used TTM to focus their attention on the 
development of a theory that would explain and organize the meaning and reasons for 
intentional behavior change. The BI part of SBIRT is a strategy by which people gain 




change (DiClemente, 2018). The BI that was used in the heart failure study, Brief 
Negotiated Interview, used motivational enhancement and cognitive behavioral 
approaches to help their patients address unhealthy thoughts and behaviors associated 
with current use patterns and acquire change strategies. This BI encompasses the many 
concepts of intentional behavior change theory. 
As applied to this study, the theoretical foundation for the efficacy of the SBIRT 
is in the TTM. The TTM aspects, known as processes of change, are cognitive and 
behavioral activities used to progress through intentional behavioral change (DiClemente, 
2018). The TTM process of intentional behavioral change theory holds that it would 
expect the independent variables, which are the severity of methamphetamine use and 
receiving SBIRT, to explain or influence the dependent variable, which is the 
rehospitalizations. The intentional behavior change can help a patient achieve goals of 
reduction or elimination of substance use in the change process (Kennedy & Gregoire, 
2009). Applying TTM in substance use and co-occurring disorders, change occurs as a 
result of increasing negative consequences and their motivational influence. Motivational 
interviewing (MI) is an approach to work with patient ambivalence and help them 
determine their ability/capacity to change and to provide them with the skills to do this. 
The SBIRT becomes the context to apply the MI treatment.  
Several studies found that readiness to change was an important predictor of 
response to substance use interventions (Carpenter et al., 2002). More specifically, 
participants who reported greater recognition that (a) their substance use was problematic 




substance use involvement (Bertholet et al., 2009; Carpenter et al., 2002). These studies 
suggest that people are more inclined to change their substance use if they are aware that 
a problem exists and recognize the need for change (Bertholet et al., 2009; Carpenter et 
al., 2002; Collins et al., 2012). SBIRT is strategic in the change process by allowing 
patients to become more aware of the effects of substance use disorders (SUDs), gain 
skills and confidence to make intentional behavior change, and find alternatives to their 
use (Roy-Byrne et al., 2014). Primary care settings provide the best context and 
opportunities for change over time since patients expect preventive care and a 
longitudinal relationship with a health care provider.  
Nature of the Study 
This study examined how SBIRT can influence rehospitalizations. This study 
examined those individuals who have tested positive for methamphetamine use, who also 
have a serious heart condition, and who have not sufficiently found ways to reduce their 
drug use to maintain heart health. Because the literature is clear about a strong linkage 
between methamphetamine use and a heart condition, in this study, avoiding 
rehospitalization served as a proxy indicator for intentional behavioral change. 
This is a quantitative study that utilized logistic regression to compare which 
variables had the most influence comparing SBIRT or the severity of methamphetamine 
use on rehospitalizations. The dependent variable (rehospitalization) is categorical 
(hospitalized = 1; not hospitalized = 0). For a categorical dependent variable when there 




logistic regression is an appropriate multivariate procedure. This allowed for comparison 
in relation to which independent variable has more influence on the dependent variable. 
The sample size has a high power to show statistical results <.05 for a bivariate 
comparison of means (mean CAGE-AID score for those rehospitalized versus those who 
are not); as well as for a chi-square analysis with SBIRT as the independent variable. I 
used SPSS to analyze secondary data to understand the theory of intentional behavior 
change that relates to rehospitalizations and the use of SBIRT and severity of 
methamphetamine use (Hosmer et al., 2013).  
In total, there were 608 hospitalizations in the year 2013, which received a 
primary diagnosis of HF. These hospitalizations also included patients with a left 
ventricular ejection fraction (LVEF) ≤ 40%, which were categorized into systolic heart 
failure. I excluded patients if they were categorized with diastolic dysfunctions only, 
were unable to care for self, had no reliable caregiver, or resided in a skilled nursing 
facility (SNF). Additionally, I excluded patients if enrolled in palliative care/hospice, 
pending cardiac surgery, or end-stage renal disease. 
The primary purpose of logistic regression is to describe data and to explain the 
relationship between one dependent binary variable and one or more nominal, ordinal, 
interval, or ratio-level independent variables (Hosmer et al., 2013).  
Definitions 
The following definitions have been provided for the terms used in this study:  
Methamphetamine use is considered a substance use disorder and is defined by 




alcohol, and/or other drugs with two or more of the following symptoms within a 12-
month period: (a) attempting to cut back on substance use without success; (b) 
consuming more of the substance than planned; (c) spending a lot of time and energy 
getting, consuming, and recovering from using the substance, often referred to as 
“craving”; (d) failing to fulfill major life obligations due to the substance use; (e) 
continuing to use the substance despite consequences; (f) giving up or reducing important 
activities due to substance use; (g) using in dangerous situations; (h) developing 
tolerance; and (i) experiencing withdrawal (American Psychiatric Association, 2013).  
Screening is defined as involving the use of specific, evidence-based 
questionnaires in verbal and written formats that detect risky alcohol and drug use 
(SAMHSA, n.d.). The questions asked during the screening are intended to measure 
quantity and frequency of substance use over defined periods of time (SAMHSA, n.d.). 
They are also designed to measure the occurrence of its adverse consequences. These 
screenings are designed to be quick, lasting only five to fifteen minutes (SAMHSA, n.d.). 
CAGE-AID screening is defined as early identification of substance use by using a 
screening tool to alert the providers to patients who need follow-up and further 
assessment of substance use patterns and their association with adverse health effects 
(SAMHSA, n.d.). The CAGE-AID screens for alcohol and drug problems. Each response 
is scored as 1. A score of 2 or higher is considered clinically significant and should raise 





Brief intervention is be defined as a nonjudgmental encounter between a health 
professional and a patient that is designed to help improve chances that the patient will 
reduce risky alcohol consumption or discontinue harmful drug use (SAMHSA, n.d.). A 
BI goes beyond the sharing of simple advice. Evidence-based approaches are used to give 
the patient tools for changing his/her beliefs about substance use and coping with 
everyday situations that exacerbate his/her risk for harmful use (SAMHSA, n.d.). Clear 
directive advice involves focusing on increasing patient insight and awareness regarding 
substance use, and encouraging behavioral change through MI and self-management 
approaches (Miller & Rollnick, 2012). 
Referral to treatment is defined as making a referral to specialized treatment for 
substance use disorders for those whose screening score indicates a severe problem or 
dependence or who find themselves unable to limit drinking (SAMHSA, n.d.). 
CAGE-AID score is defined as each response receiving a score of 1. Score 1 is a 
possible low-risk SUD. Score 2 is a probable moderate risk for SUDs or at-risk use. A 
Score 3 or higher is considered clinically significant and high-risk, and should raise the 
clinician’s suspicion that the individual has a SUD problem or disorder (Ewing, 1984). 
Ejection fraction (EF) is defined as the measurement in determining how well the 
patient’s heart is pumping out blood with each contraction and in diagnosing and tracking 
heart failure (American Heart Association, n.d.). 
Heart failure stage is defined as a rating system to evaluate the development and 
progression of heart failure symptoms. The system includes four stages. Stages A and B 




coronary artery disease, high blood pressure, diabetes, or other predisposing conditions. 
Stage C includes patients with past or current symptoms of heart failure who have a 
condition called structural heart disease. Stage D includes patients who have advanced 
heart failure that is difficult to manage with standard treatment (Horsley, 2010). 
Hospital readmissions is defined as multiple inpatient stays within a specified 
time period (30-60-90 days) by the same patient (Hersh et al., 2013). 
Limitations 
Because I examined a patient cohort with mild-to-moderate SUD, I assumed that 
they will have greater motivation for change than those patients with a severe chronic 
relapsing level of SUD severity. The current retrospective study had a scope and 
limitations that restricted the research questions that can be answered. Socioeconomic 
issues, access to therapy, access to health care—which all contribute to the higher 
incident of health risks—were beyond the scope of this study. I did not look at the severe 
chronic relapsing level of SUD severity but mild to moderate SUD. Furthermore, my 
sample did not consist of random sampling, but rather a census study, because I gathered 
data on every member of the population. The boundaries for this study were set to 
facilitate interpretation of the results and helped to arrive at meaningful conclusions.  
Threats to reliability serve as study limitations. These may include the subjective 
responses to CAGE-AID and participants under reporting the severity of their SUD. 
Another threat could be that those patients who volunteer for treatment might be more 
motivated to change than those patients who did not participate in treatment, and so the 





This research filled a gap in understanding the links between rehospitalizations 
and the effects of SBIRT and severity of methamphetamine use with patients who have 
chronic health conditions (Saitz et al., 2012). This project is unique because it addressed 
an under-researched area for individuals with mild and moderate substance use problems 
with comorbid medical conditions. The potential for positive social change is for 
treatment providers to understand that SBIRT is a general approach and not a specific 
technique. SBIRT needs to be modified for use in various settings. A one-size-fits-all 
approach to address substance use does not work (Zgierska et al., 2014). The results of 
this study will also help health care providers such as doctors, nurses, and health 
educators and social workers to assist in patient substance use recovery and coordinate 
patient discharge and continuity of care following discharge (NASW, 2014).  
The potential significance of this research is that it contributed to the existing 
body of SBIRT literature by helping to understand how SBIRT might benefit patients 
with mild to moderate methamphetamine use. It is essential to note that the efficacy of 
SBIRT reducing or eliminating methamphetamine use has not been investigated and 
addressed with patients with heart failure. 
Summary 
The current study examined the effectiveness of the use of SBIRT for the 
treatment of mild-to-moderate methamphetamine use disorder. The purpose of this study 
was to add to the body of knowledge on ways to treat methamphetamine use disorder and 




either caused by or exacerbated by continued methamphetamine abuse. SBIRT is an 
evidence-based practice for the treatment of substance use disorders, and the abbreviation 
SBIRT is referenced as such were defined in this chapter. The research question for this 
study is: How can SBIRT reduce and/or eliminate the compulsive use of 
methamphetamine in a heart failure patient population? The background information 
related to this study suggested that continued compulsive methamphetamine abuse, 
despite adverse medical consequences, including cardiac problems, are a complication for 
patients within a hospital-based heart failure program. The nature of this study involved a 
quantitative approach to examine the efficacy of SBIRT on reducing compulsive 
methamphetamine abuse with these patients within hospital-based heart failure program 
and thereby reducing the frequency of postdischarge complications. Specifically, I used a 
quantitative multiple regression in this study. In the next chapter, I review the existing 





Chapter 2: Literature Review 
Methamphetamine is one of the most commonly abused illicit drugs in the United 
States (Paratz et al., 2016; Tarango & Baird, 2018). Health care providers are constantly 
faced with medical complications caused by methamphetamine (Paratz et al., 2016; 
Tarango & Baird, 2018). It is established that methamphetamine use is an independent 
risk factor for an increase in the severity of heart failure and cardiomyopathy (Stanford, 
2009; Tarango & Baird, 2018). There has been a significant amount of research that has 
identified the efficacy of the use of SBIRT for reducing the problem of alcohol use 
(SAMSHA, n.d.). However, during the past 5 years, there are few research studies that 
demonstrate the effectiveness for reducing illicit drug use among non-treatment-seeking 
patients (Saitz, 2014). These issues warrant an exploration for the effectiveness of the use 
of SBIRT for the treatment of mild to moderate methamphetamine use disorder 
particularly with a patient cohort who have been hospitalized for cardiac complications 
either caused by or exacerbated by continued methamphetamine abuse. 
A literature review is an objective, critical summary of published research 
literature relevant to a topic under consideration for research. Its purpose is to create 
familiarity with current thinking and research on a topic and may justify future research 
into a previously overlooked or understudied area (Creswell, 2009). To begin, I present a 
review of the research strategies for locating articles for future research or examination. 
Next, I present a review of the research with the presentation of seminal research and the 
current state of knowledge related to methamphetamine use and heart failure, evidence of 




specifically to SBIRT in primary care settings. Finally, I make recommendations for 
moving forward in the treatment of methamphetamine use disorder and particularly with 
a patient cohort who have been hospitalized for cardiac complications either caused by or 
exacerbated by continued methamphetamine abuse.  
Research Strategy 
I conducted a literature review by using a writing strategy that began with a focus 
on the broad topic of substance abuse and SBIRT. I then narrowed the focus to 
methamphetamine abuse and the use of SBIRT in primary care settings. Last, I focused 
the research on patients receiving an SBIRT intervention who have been hospitalized for 
cardiac complications either caused by or exacerbated by continued methamphetamine 
abuse.  
I conducted a literature research using the Walden University online library in 
tracing back to primary sources from secondary sources. I also consulted ProQuest 
Central to pursue lines of inquiry related to the study, and SAGE journals and Google 
Scholar to find relevant, peer-reviewed articles. I sourced local statistical information 
from the United Nations Office on Drugs and Crime National and The SAMHSA 
websites. 
The search began by accessing multiple databases, with limiters set for peer-
reviewed, full-text articles dating back to 2012. I used search engines such as PsycINFO 
and SocINDEX. I used combinations of the following keywords and terms by employing 
Boolean identifiers to search the aforementioned data bases: substance use; substance 




SBIRT; primary care; primary health care; BI; TTM; motivational interviewing; 
motivational therapy; process of change; stages of change; and transtheoretical model. A 
breadth of articles emerged from various authors. I used each term within each of the 
three databases until I established saturation by overlapping results. Because there was no 
research found examining the intersection between patients receiving an SBIRT 
intervention who have been hospitalized for cardiac complications either caused by or 
exacerbated by mild to moderate methamphetamine abuse, the contents of this literature 
review are limited to the examination of the use of SBIRT in primary care with individual 
and organizational factors independently that influence client outcomes. 
Theoretical Framework 
The theoretical base for this study is the TTM. The TTM began in the 1970s as an 
attempt to delineate an overarching behavior change process (Migneault et al., 2005). 
This health behavior change model has been used for more than 30 years. According to 
DiClemente (2018), the process of intentional behavior change can be explained through 
the core dimensions of the TTM. The model’s initial insight stated that process change 
only happened in the framework of the stages of change. As DiClemente’s research 
progressed, it became evident that the process of change expanded (DiClemente, 2018). 
There are two types of processes of change involved in intentional behavior change. One 
type represents cognitive and experiential processes which involves thinking and feeling, 
such as consciousness raising: gaining information that increases awareness about the 
current behavior pattern or the potential for a new behavior. The second type, action-




habit, such as reinforcement management: identifying and manipulating the positive and 
negative reinforcers for current or new behavior. Intentional behavior change requires 
creating rewards for new behaviors while eliminating reinforcements for current 
behaviors. 
The TTM provides suggested strategies such as SBIRT for public health 
interventions to address intentional behavior change. The aspect that makes the TTM 
unique is the idea that change occurs over time, an aspect overlooked by other theories of 
change (Prochaska et al.,1992). In the TTM, behavior change is treated as dynamic. This 
distinction is considered one of the theory’s strengths (Marshall & Biddle, 2001). 
DiClemente et al. (2004) used TTM to focus their attention on the development of a 
theory that would explain and organize the meaning and reasons for intentional behavior 
change. The BI part of SBIRT is a strategy by which people gain skills and confidence to 
help people to understand and move through intentional behavioral change (DiClemente, 
2018). The BI that was used in the heart failure study, brief negotiated interview, used 
motivational enhancement and cognitive behavioral approaches to help patients address 
unhealthy cognitions and behaviors associated with current use patterns and adopt change 
strategies. This BI encompasses the many concepts of intentional behavior change theory. 
As applied to this study, the theoretical foundation for the efficacy of the SBIRT 
is in the TTM. The TTM aspect known as processes of change are cognitive and 
behavioral activities that people use to progress through intentional behavioral change 
(DiClemente, 2018). This theory holds that it would expect the independent variables, 




influence the dependent variable which is the rehospitalizations because TTM process of 
change theory involves intentional behavior change. The intentional behavior change can 
help a patient achieve goals of reduction or elimination of substance use in the change 
process (Kennedy & Gregoire, 2009). Applying TTM in substance use and co-occurring 
disorders, change occurs as a result of increasing negative consequences and their 
motivational influence. MI is an approach to work with patient ambivalence and help 
them determine their ability/capacity to change and to provide them with the skills to do 
this. The SBIRT becomes the context to apply the MI treatment.  
Several studies found that readiness to change was an important predictor of 
response to substance use interventions. More specifically, participants who reported 
greater recognition that their substance use was problematic and of the need for change 
reported larger reductions in their post-intervention substance use involvement (Bertholet 
et al., 2009; Carpenter et al., 2002; Collins et al., 2012). These studies suggest that people 
are more inclined to change their substance use if they are aware that a problem exists 
and recognize the need for change (Bertholet et al., 2009; Carpenter et al., 2002; Collins 
et al., 2012). SBIRT is strategic in the change process by allowing patients to become 
more aware of the effects of SUD, gain skills and confidence to make intentional 
behavior change, and find alternatives to use (Roy-Byrne et al., 2014). Primary care 
settings provide the best context and opportunities for change with time, because patients 






Methamphetamine is one of the most commonly abused illicit drugs in the United 
States (Karch, 2011; UNODC, 2017). Methamphetamine is highly addictive in nature and 
is difficult to cease use (NIDA, 2013; Stanford, 2009). Methamphetamine is a 
psychostimulant drug. Methamphetamine causes the release of the neurotransmitters such 
as dopamine, norepinephrine, and serotonin (NIDA, 2013; Stanford, 2009). The 
neurotransmitters activate the cardiovascular and central nervous systems (NIDA, 2013; 
Stanford, 2009). The short-term side effects of methamphetamine use include increased 
energy and alertness, euphoria, the decreased need for sleep, increased sexuality, and 
weight loss (NIDA, 2013; Stanford, 2009). It is metabolized more slowly than other 
stimulants. The drug remains in one’s system depending on individual factors. 
Methamphetamine can have a 9- to 13-hour half-life (NIDA, 2013; Stanford, 2009). 
Cocaine has a half-life of approximately 30 minutes, thereby making methamphetamine a 
potentially more popular drug, given the longer results it offers (Fowler et al., 2008; 
NIDA, 2013; Stanford, 2009). Methamphetamine use also has negative consequences 
including a dry mouth that can lead to tooth decay. Other symptoms may include chronic 
adverse mood and cognitive changes, including irritability, anxiety, aggression, panic, 
suspiciousness and paranoia, hallucinations, executive dysfunction, and memory 
impairment (McKetin et al., 2016; NIDA, 2013; Stanford, 2009). 
Methamphetamine can also exacerbate existing psychiatric symptoms (NIDA, 
2013). When patients attempt to cease use, they may experience the following symptoms 




performance, increased hunger and food consumption, insomnia or hypersomnia, and 
psychomotor agitation (McKetin et al., 2016; NIDA, 2013; Stanford, 2009). These 
negative symptoms are associated with cessation that drives patients to continue 
methamphetamine use (McKetin et al., 2016; NIDA, 2013). Furthermore, there is 
currently no prescription therapy available to aid in the cessation of methamphetamine 
addiction (NIDA, 2013; Stanford & Avoy, 2006). These patients tend to present more 
frequently for medical conditions caused by or exacerbated by continued 
methamphetamine use (NIDA, 2013). 
Health care providers are frequently faced with a medical illness caused by 
methamphetamine use (Kaye et al., 2007). A vast number of physical ailments are 
associated with methamphetamine use, including stroke; heart attack; damage to liver, 
kidney, and lungs; injuries; and death (Darke et al., 2017). Methamphetamine can also 
exacerbate several chronic medical conditions, including hypertension and heart failure 
(NIDA, 2013). 
Because this drug was first introduced, the prevalence of methamphetamine 
toxicity has increased around the world. Three different retrospective autopsy series have 
been published on methamphetamine-related deaths (Logan et al., 1998). The studies 
explained the manifestations of methamphetamine cardiotoxicity, with the most common 
being myocardial infarction, aneurysm, and cardiomyopathy. These studies 
microscopically examined the hearts of methamphetamine users, and these cases 




Methamphetamine-associated cardiomyopathy was first reported in the United 
States in the late 1980s (Derlet et al., 1990). It is recognized that methamphetamine-
associated cardiomyopathy predominately presents as heart failure with reduced ejection 
fraction (EF), with an EF of less than 40% (Richards et al., 2018). It has been 
documented that the risk of hospitalization and death due to heart failure is strongly 
correlated with severe cardiomyopathy (Kaye et al., 2007; Richards et al., 2018). 
Methamphetamine users are at a higher risk for adverse medical outcomes (Kaye et al., 
2007; Richards et al., 2018). 
According to the National Survey on Drug Use & Health ([NSDUH], 2014), 
SAMHSA reported illicit drug use in the United States has been increasing. In 2015, 
approximately 897,000 people, aged 12 years or older, were current users of 
methamphetamine, an increase from 569,00 the prior year (UNODC, 2017). Visits to the 
emergency department have also increased significantly (UNODC, 2017). Worldwide, 
approximately 37 million people use amphetamine and prescription stimulants in one 
form or another. Amphetamine and prescription stimulants are the most commonly used 
and misused drug second only to cannabis (UNODC, 2017). 
In California, 20- to 29-year-olds comprised 34% of all individuals admitted to 
treatment for primary methamphetamine use, and it is the primary drug responsible for 
26% of all admissions (SAMHSA, n.d.). Based on these statistics, it seems the prevalence 
of heart failure from methamphetamine continues to increase and the use of 




issues require health care providers to offer interventions targeted toward the patient’s 
substance use that are tailored to each patient’s needs (Tarango & Baird, 2018). 
Screening, Brief Intervention, Referral to Treatment (SBIRT) 
One framework that can be used by healthcare providers in any setting for 
approaching harmful substance use is the SBIRT model (SAMHSA, 2011). SAMHSA 
developed the SBIRT model as a comprehensive, integrated, public health approach for 
persons with substance use disorders, as well as those who are at risk of developing these 
disorders (SAMHSA, 2011). Research has demonstrated SBIRT’s numerous benefits. 
Specifically, SBIRT successfully reduces healthcare costs; the severity of drug and 
alcohol use; risk of trauma; and the percentage of at-risk patients who do not receive 
specialized substance use treatment (Quanbeck et al., 2010). SBIRT consists of three 
major components:  
Screening: a healthcare professional assesses a patient for risky substance use 
behaviors using screening tools (Bien et al., 1993).  
Brief Intervention: a healthcare professional engages a patient showing risky 
substance use behaviors in a short conversation providing feedback (Bien et al., 
1993). 
Referral to Treatment: a healthcare professional provides a referral to brief 
therapy or additional treatment to a patient who screens in need of an increase of 
services (Bien et al., 1993). SBIRT is an evidenced-based practice used to 
identify, reduce, and prevent risky use, abuse, and dependence on alcohol and 




healthcare professionals to universally screen and support patients who may not 
be seeking help for a substance use problem, but whose drinking or drug use may 
affect their ability to successfully handle health, work, or family issues (USPSTF, 
2004). The SBIRT approach aims to prevent the consequences of alcohol and 
drug use for patients that may engage in risky use that do not meet the criteria for 
a diagnostic level of a substance use disorder. SBIRT also helps those with the 
disease of addiction enter and stay with treatment (USPSTF, 2004).  
Alcohol Use Disorder 
There are significant results from several review studies (Babor et al., 2007; Bien 
et al., 1993; Kaner et al., 2009) and meta-analyses of randomized clinical trials (Beich et 
al., 2003; Bertholet et al., 2009) that demonstrate the effectiveness of SBIRT in reducing 
problematic drinking in patients presenting in primary care settings. Babor et al. (2007) 
described research on the components of SBIRT conducted during the past 25 years. 
These reviews discussed the development of screening tests, clinical trials of BI, and 
implementation research. Based on the result of this review, BI are effective with 
smokers and risky drinkers, and there is some evidence that they work well with 
marijuana users. Brief treatments are effective with persons who are dependent on 
alcohol, marijuana, or other drugs.  
Studies have indicated that SBIRT is effective in adult primary care in reducing 
risky alcohol misuse (Moyer, 2013). It is evident in the literature that providing BI for 
patients with alcohol problems are effective in a variety of healthcare settings including 




1997; Gentilello et al., 1999). Experimental studies have indicated screening and BI 
delivered in health care settings to have efficacy for reducing risky alcohol consumption 
(D’Onofrio & Degutis, 2002; Fleming et al., 1997; Gentilello et al., 1999). 
The SBIRT approach can address the continuum of care for alcohol problems. 
Based on the severity of alcohol use indicated by the screening results, interventions can 
be brief, or referrals can be made to traditional specialty treatment for patients (Kunz et 
al., 2004). For at-risk individuals, SBIRT screen for early identification of alcohol misuse 
and BI around normative use misperceptions and skills enhancement. SBIRT strategies 
have demonstrated to be effective in decreasing consumption and binge drinking 
(Hanewinkel & Wiborg 2005; Martens et al., 2007; Murphy et al., 2001; Toumbourou et 
al. 2007). The evidence further demonstrates that SBIRT may not necessarily be 
conducted and provided by physicians. Rather, SBIRT can be provided by allied health 
professionals such as nurses, counselors, health educators, and peers (Marlatt, 2004).  
Substance Use Disorder 
Based on the limited published research on SBIRT for drugs, in 1995 the United 
States Preventive Services Task Force (USPSTF) concluded that there was insufficient 
evidence for the effectiveness of using an SBIRT approach for drugs. Some researchers 
have cited the scarcity of validated, brief drug-screening tools and the low prevalence 
rates of drug use in primary care settings, as two reasons for the of insufficient amount of 
studies showing SBIRT’s effects with drugs (De Micheli et al., 2004; Saitz, 2010; Smith 




Nevertheless, there has been an increase in research as well as findings from 
SAMHSA-funded SBIRT projects that have shown effective results for the use of the 
SBIRT approach in reducing risky drug use (Copeland et al., 2001). Moreover, a 
randomized controlled trial indicated that BI could reduce cocaine and heroin use 
(Bernstein et al., 2005). Bernstein et al. (2005) studied illicit drug screening and 
intervention for adults in an urgent care setting. Bernstein et al. screened 23,660 patients 
from women’s health, homeless, and urgent care clinics and randomized those who 
screened positive for risky cocaine or heroin use (N = 1175) to a brief negotiated 
interview or received a referral list and written advice. To draw valid conclusions, 
adequate follow-up is needed. Ninety-five percent of eligible subjects were enrolled, and 
82% were available for follow-up. At six months, abstinence was documented among 
40% of the intervention subjects and 31% of the control subjects (Bernstein et al., 2005).  
Although SBI has proven effective for alcohol and drug use in some healthcare 
settings and some populations, more research needs to be conducted to determine the 
benefit with drug users identified in primary care settings. This study also lends to the 
need for feasible and effective BI for drug use primary care settings where patients with 
chronic medical conditions. In other research, BI for patients screening positive for illicit 
substances such as cocaine, heroin, and amphetamine is also showing results in various 
healthcare settings beyond emergency departments (Cunningham et al., 2009).  
Madras et al. (2008) conducted an observational before-and-after study. Based on 
small sample sizes, screening and BI were linked with reductions in the use of marijuana, 




initially screening participants, Madras et al. found a 68% decrease in self-reported drug 
use and improvement in overall health, employment, criminal justice involvement, and 
housing status. This study did not control for biological outcome confirmations and relied 
on self-reports (Madras et al., 2008). The study would need to caution the results due to 
other explanations of decreased use besides SBI. A decrease in use can be due to self-
change or regression to the mean. Although this before-and-after, retrospective 
uncontrolled study informs the question of whether drug SBI has efficacy in primary 
care, it still does not establish meaningful outcomes. This study demonstrated the need 
for randomized controlled trials of drug SBI in adult primary care settings to be published 
in peer-reviewed literature. 
Humeniuk et al. (2012) demonstrated the need for further research due to the 
difficulty in comparing this study to others due to the differences in the elements of each 
study presented, such as the interventions being one session, phone sessions, and use of 
pamphlets. Further studies are needed given the widespread implementation of SBIRT. 
The World Health Organization supported a multi-national study where it was evident 
that SBIRT resulted in short-term reductions of illicit drugs such as marijuana, cocaine, 
amphetamine-type stimulants, and opioids (Humeniuk et al., 2012).  
Humeniuk et al. (2012) conducted a large multicenter international study. The 
World Health Organization randomized a trial of a single BI in five countries. Patients 
were recruited from sexually transmitted disease clinics, dental, walk-in clinics, and 
community medical care sites. The findings showed minimal difference favoring the BI 




36; the BI group had a reduced score of 30 while the control group score was reduced to 
32, a 2-point difference in a scale with a maximum score of 338. The United States was 
the only site where the control group had a greater decrease in the score. Some 
implications to consider when interpreting these results are that the study excluded those 
who have moderate to severe disorder and no biological testing.  
In contrast, there is currently insufficient evidence to conclude the effectiveness 
of BI for reducing illicit drug use among non-treatment-seeking populations (Saitz et al., 
2012). Saitz et al. (2012) acknowledged that SBI has proven effective for unhealthy 
alcohol use, but there is a concern that drug SBI may have limited or no efficacy. The 
researchers advocate for the need of drug SBI to improve drug use outcomes. They argue 
that more randomized controlled trials are urgently needed. Saitz et al. cautioned BI for 
drug use in general health settings due to the possibility that patients may use more than 
one drug or use alcohol and another drug, making BI more complicated than it is for 
alcohol use. Discussing drug use may cause challenges as clinicians struggle to 
distinguish between appropriate use and inappropriate use of illicit drugs. An additional 
reason for the researchers to posit that there is not sufficient evidence to support 
recommendations for universal drug SBI is due to the challenge of distinguishing patients 
who seek help to those identified by screening. Saitz et al. concluded BI might have 
different outcomes among those seeking help versus those not seeking help. However, 
after examining the reasons for caution in using BI for drug use, determining the efficacy 
in primary care requires different models of SBI that are economically sound and 




Building on previous studies, Hersh et al. (2013) explored the influence of the 
SBIRT approach effectiveness based on the intensity and frequency of the BI 
intervention. Hersh et al. conducted their study in three Federally Qualified Healthcare 
Centers (FQHCs). A total of 10,935 patients were screened, and 600 individuals were 
recruited. Participants were randomly assigned to receive one session of BI, or two to six 
sessions of BI that had elements of motivational therapy and cognitive-behavioral 
therapy. Participants completed follow-up assessments every three months for one year. 
The primary outcome—BI—could influence substance use, but the research findings 
have been mixed.  
The researchers hypothesized that the lack of efficacy for illicit drug use and more 
severe alcohol use might be explained by intensity and frequency of intervention. The 
multiple linked BI for illicit drug use and more severe alcohol demonstrated to be more 
effective than a single session of SBIRT. The severe alcohol users and illicit drug users 
responded to a more expansive intervention included elements of brief treatment (Hersh 
et al., 2013). This study furthered an understanding of SBIRT’s effectiveness when 
SBIRT works, for whom, and what intensity is most appropriate to substances used and 
severity. 
Roy-Byrne et al. (2014) researched whether the BI improves drug use outcomes 
compared with enhanced care as usual. One group received a single BI using 
motivational interviewing, a handout and list of substance abuse resources, as an 
attempted 10-minute telephone booster within two weeks (Roy-Byrne et al., 2014). The 




substance abuse resources. The one-time BI with attempted telephone booster did not 
affect drug use patterns seen in safety-net primary care settings (Roy-Byrne et al., 2014).  
Although this study showed no effectiveness, this may have been influenced due 
to participants receiving only one single BI. Expecting risky substance use to stabilize or 
remit in one or two sessions of BNI is unrealistic. Multiple sessions by the clinician are 
often necessary. Brief treatment was not mentioned in this study. Second, the study 
measured frequency but not the quantity of drug use in a limited measure of outcomes 
(Roy-Byrne et al., 2014). Currently, there is no gold standard for quantifying problem 
drug use. Researchers must find a way to measure the quantity as well as the frequency of 
use.  
Another study shared a similar limitation, demonstrating that all BI are not the 
same and their summary characterizations in reviews may be inadequate. Gelberg et al. 
(2014) preliminarily reported a randomized trial of drug SBI in primary care. The 
intervention was less than five minutes of brief advice, then a video doctor repeating the 
advice, and two follow-up counseling sessions. Results were a greater reduction in the 
drug use days in the intervention group versus the control group, among those who used 
drugs more frequently (N = 334, identified from more than 15,000 screenings; Gelberg et 
al., 2014). The intervention reduced self-report drug use by two days. The validity 
concerns with this study include the social desirability bias and the absence of laboratory 
testing to corroborate outcomes. Participants who had two or more contacts had better 
outcomes. It would benefit researchers to redefine “brief intervention” and explore how 




Moreover, a quasi-experimental study examined the effectiveness of the SBIRT at 
a community health center (Dwinnels, 2015). The results suggest that in an outpatient 
clinic, SBIRT is effective in identifying patients at risk for depression, alcohol, and 
substance use. This study proved to influence the improvement of identification and 
diagnosis, despite research indicating low efficacy of BI for drug use found through 
screening in the primary care setting. Dwinnells (2015) and Saitz et al. (2012) supported 
the integration of behavioral health with specialty care where there are major unmet 
health needs, such as chronic illnesses and substance use.  
Chronic Illness and Substance Use 
Methamphetamine use can exacerbate several chronic medical conditions, 
including hypertension and heart failure (NIDA, 2013; Stanford, 2009). Wijetunga, Seto, 
Linday, and Schatz (2013) analyzed patients discharged from a tertiary-care hospital with 
the diagnosis of cardiomyopathy over four years. More than 1,600 patients were 
identified, of whom 120 had been diagnosed with substance abuse as well. Substance 
abuse was documented by the patient’s clinician; the clinician’s documentation may have 
underestimated the overall prevalence of methamphetamine use. There is an unclear 
window during which reversibility of cardiac dysfunction can occur with the cessation of 
methamphetamine. Patients with substance use have a greater prevalence of chronic 
medical conditions as demonstrated in this study (Wijetunga et al., 2013). These findings 
demonstrate the importance of health care professionals having the role of identifying and 




Methamphetamine use complicates the effective management of heart failure and 
can worsen the severity of patients’ heart condition. Yeo et al. (2007) performed a case-
control study looking at patients less than 45 years old and discharged from a hospital 
with the diagnosis of either congestive heart failure or cardiomyopathy. 
Methamphetamine users had 3.7 increased odds ratio of congestive heart failure or 
cardiomyopathy as compared with controls (Yeo et al., 2007). This study controlled age-
matched, hospitalized patients who had an echocardiogram with normal LVEF of 55% or 
more and no wall-motion abnormalities. These researchers demonstrated the growing 
body of evidence that the development of dilated cardiomyopathy is related to chronic 
methamphetamine use.  
Methamphetamine use is associated with higher rates of a chronic medical 
condition (NIDA, 2013; Stanford, 2009; Yeo et al., 2007). Substance use plays a role in 
the development and exacerbation of chronic medical conditions such as heart failure. 
Therefore, it is important for health care practitioners to detect and address substance use 
in populations with chronic health conditions such as heart failure. Finally, further 
research can emphasize the importance of identifying and treating substance use in this 
patient population of chronic medical conditions to improve management and long-term 
outcomes of these comorbid conditions.  
Summary 
This study is significant because it begins to fill the information gap in the 
existing literature regarding the links between rehospitalizations and the influence of 




conditions, specifically within patients with heart failure (Saitz et al., 2012). This study 
contributes to a body of SBIRT literature. Furthermore, this study promotes the learning 
and understanding of how SBIRT might benefit patients with mild to moderate 
methamphetamine use. The literature reviewed has focused on the effectiveness of BI as 
part of the SBIRT model for reducing substance use, specifically methamphetamine use 
disorder.  
Conclusion 
Substance use is common among patients in primary care settings. SBIRT has a 
substantial health influence and is an effective approach that includes a coherent 
framework to identify and manage substance use disorders and specific strategies to 
promote behavior change. Brief validated screening tools allow rapid and efficient 
identification of problematic drug use, including methamphetamine use disorder. After a 
positive screening, a brief assessment is performed to stratify patients according to 
severity: mild-moderate-severe use. Despite the lack of evidence that screening for 
substance use disorders in general, and methamphetamine use disorder in particular, 
improves outcomes, universal screening may be justified based on the high prevalence 
and morbidity of substance use and proven effectiveness of treatment. In patients with 
positive screening results, methamphetamine use should be stratified into mild-moderate-
severe chronic relapsing use. Brief counseling is indicated for patients with mild to 
moderate substance use disorder (SUD). Patients with a more severe subtype of SUD 




Substance use is characterized by the development of consequences from use, and 
these consequences can serve as motivators for change. In primary care settings, medical 
consequences from substance use can be instrumental in increasing motivation. Principles 
and techniques derived from MI are used to manage ambivalence and increase readiness 
to change. Developing a plan for change is an opportunity for the provider within a 
primary care/hospital setting. Referral for specialty addiction treatment is recommended 
for patients with severe chronically relapsing SUD. Access to specialty treatment is 
variable, and decisions about where to refer patients must take into account local 
resources and patient characteristics. Even in specialty addiction treatment, patients 





Chapter 3: Research Method 
The purpose of this quantitative study using an existing dataset was to test the 
theory of intentional behavior change that relates to rehospitalizations. Rehospitalization 
is based on the severity of methamphetamine abuse using the CAGE-AID score and 
receiving a SBIRT in the Heart Failure Program at a Santa Clara County hospital.  
In Chapter 3 of this study, I introduce the research question along with details 
about the dependent and independent variables. In the chapter, I also define the target 
population. I then explain the sampling and data collection for this study. I provide 
operationalization for each variable and describe the threats to validity and address 
ethical procedures. Chapters 4 and 5 consist of the data analysis and findings of the 
research. 
Research Question 
The research question for this study was as follows: Does the SBIRT intervention 
increase the patient’s ability to make a behavioral change and therefore make a difference 
in rehospitalizations for patients with heart failure who screen positive for 
methamphetamine use? 
H01: There is no relationship between the dependent variable (rehospitalization) 
when compared to the independent variables (SBIRT). 
H11: There is a relationship between the dependent variable (rehospitalization) 
when compared to the independent variables (SBIRT). 
H01: There is no relationship between the dependent variable (rehospitalization) 




H11: There is a relationship between the dependent variable (rehospitalization) 
when compared to the independent variables (CAGE-AID score). 
Research Design and Rationale 
This quantitative study used an existing dataset to test the theory of intentional 
behavior change that relates to rehospitalizations based on the severity of 
methamphetamine abuse (a) using the CAGE-AID score and (b) receiving a SBIRT in the 
Heart Failure Program at a Santa Clara County hospital. The research design is a quasi-
experimental, posttest only design with an observational comparison group. It was not 
feasible to establish a randomized control group due to the nature of this community 
intervention—it would not have been feasible to withhold SBIRT or substitute an 
alternative intervention in a randomized control group in a community hospital.  
Methodology 
A Heart Failure (HF) Program at a Santa Clara Valley Medical Center (SCVMC) 
was established in late 2011. The goal was to formulate a multidisciplinary approach to 
improve the transition of care and to reduce readmissions for SCVMC HF patients. 
Through collaboration with the Department of Alcohol and Drug Services (DADS), a 
licensed clinical social worker (LCSW) was added to the HF program in October 2013. 
The data presented in this report include a 52-week analysis. 
Data were extracted from all hospitalized patients at SCVMC with a primary 
discharge diagnosis of HF in the calendar year of 2013. In total, there were 608 patient 
hospitalizations that received a primary diagnosis of HF. Because the addition of the 




diagnoses of HF have been referred for SBIRT and if eligible, for an upgrade to 
residential treatment. The inclusion criteria for the Heart Failure program were patients 
with Heart Failure and LVEF ≤ 40%. A normal LVEF ranges from 55% to 70% (Tarango 
& Baird, 2018). An LVEF of 65%, for example, means that 65% of the total amount of 
blood in the left ventricle is pumped out with each heartbeat (Tarango & Baird, 2018). 
The following exclusion criteria for the HF program study and this current study included 
patients in Stage A or with diastolic dysfunction only due to other diseases that may 
cause diastolic heart failure such as high blood pressure, diabetes, kidney disease, 
coronary artery disease, or atrial fibrillation, a heart rhythm disorder. Other exclusions 
included patients who are unable to care for self, have no reliable caregiver or residing in 
a SNF; patients enrolled in palliative care/hospice; patients pending cardiac surgery; or 
patients with end-stage renal disease. 
Sampling Procedures 
In logistic regression, the multivariate analysis proposed for this project, the 
exponentiated beta, or odds ratio, is considered to be a reasonable effect size given a 
dichotomous dependent variable. For this project, with a sample size of 375, an alpha of 
.05, an anticipated multivariate model R2 of 0.1, and an anticipated odds ratio (effect size) 
of 1.50 for the “group assignment” variable (SBIRT versus no SBIRT), the expected 
power to find statistical significance is 0.96, as calculated using GPower 3.1 (Faul et al., 
2007). I used SPSS to analyze secondary data to understand the theory of intentional 
behavior change that relates to rehospitalizations and the use of SBIRT and severity of 




were positive for methamphetamines from a total of 608. Of those 375 patients with heart 
failure, 75 did not receive a BI.  
Study Procedures 
According to SAMHSA standards, the HF program used research based on a 
comprehensive behavioral health SBIRT model to address the substance use in their 
patients with heart failure, which reflected the six following characteristics:  
1. It was brief. The initial screening was accomplished quickly (modal time 
about 5–10 minutes) and the intervention and treatment components 
indicated by the screening results were completed in significantly less time 
than traditional substance abuse specialty care (SAMHSA, 2011). 
2. The screening was universal. The patients were all screened as part of the 
standard intake process (SAMHSA, 2011).  
3. One or more specific behaviors were targeted. The screening tool 
addressed a specific behavioral characteristic deemed to be problematic, or 
pre-conditional to substance dependence or other diagnoses (SAMHSA, 
2011).  
4. The services occurred in a public health, or other nonsubstance abuse 
treatment setting. This may be an emergency department, primary care 
physician’s office, and school (SAMHSA, 2011). 
5. It was comprehensive. The program included a seamless transition 
between brief universal screening, BI and brief treatment, and referral to 




6. Strong research or substantial experiential evidence supported the model. 
At a minimum, programmatic outcomes demonstrated a successful 
approach (SAMHSA, 2011). 
The HF Program’s SBIRT screening component consisted of the CAGE-AID 
screening. There are many instruments available for screening and a brief assessment of 
alcohol and drug problems. Their effectiveness varies according to their availability, ease 
of administration, and test characteristics (Fiellin et al., 2000). Screening is a quick, 
simple method of identifying patients who use substances at at-risk or risky levels and 
who may already have substance use-related disorders (Bien et al., 1993). A screening 
instrument provides specific information and feedback to the patient related to his or her 
substance use. A common screening process involves the use of a brief one- to three-
question screen such as the CAGE-AID screen.  
For this study, the screening tool used in the HF Program at Valley Medical 
Center, which also serves as a pre- and post-test measure in the study, was the CAGE-
Adapted to Include Drug use (CAGE-AID). The CAGE-AID modifies the CAGE 
questions for use in screening for drugs other than alcohol. CAGE represents the four 
questions of the tool: cut down, annoyed, guilty, and eye-opener. The CAGE is a widely 
used screening test for problem drinking and potential alcohol problems (Mayfield et al., 
1974). The CAGE questionnaire takes less than one minute to administer. The CAGE is 
used in primary care or other general settings as a quick screening tool (Mayfield et al., 
1974). Example CAGE questions are as follows: (a) Have you ever felt you should cut 




Have you ever felt bad or guilty about your drinking?; and (d) Have you ever had a drink 
first thing in the morning to steady your nerves or to get rid of a hangover (eye-opener)?  
Like the CAGE, the CAGE-AID focuses on lifetime use (Mayfield et al., 1974). 
In a study of its usefulness in a community family practice (Brown & Rounds, 1995), it 
had a sensitivity to detect the extent of a drug or alcohol problem of 79% and a 
specificity of 77%. The authors suggested that stigma associated with illicit drugs may 
have limited its sensitivity. Stigma is a problem with any substance-use screening 
instrument, but less so with the CAGE since it was designed to be less stigmatizing in 
nature than other drug/alcohol use inventories. Limitations of the CAGE-AID are similar 
to the CAGE in that it does not distinguish between active and inactive problems and has 
not been validated for identifying hazardous or harmful use. The following are example 
questions from the CAGE-Adapted to Include Drugs (CAGE-AID) (Mayfield et al., 
1974): 
C: Have you ever thought you should Cut down on your drug use? 
A: Have people Annoyed you by criticizing your drug use? 
G: Have you ever felt bad or Guilty about your drug use? 
E: Have you ever used drugs first thing in the morning to steady your nerves or 
avoid withdrawal (Eye opener)? 
This study reviewed patient electronic health records to view the scores of the 
CAGE-AID screening. The CAGE-AID is a continuous independent variable based on 
numerical value-interval 1–4. The CAGE-AID is a four-item survey about covert 




found to be a reliable predictor of problem drinking (Mayfield et al., 1974). National 
Institute on Alcohol Abuse and Alcoholism (NIAAA) has traditionally recommended that 
the practitioner asks quantity and frequency questions followed by the CAGE screening 
(Ewing, 1984). Each response is scored as 1. A score of 2 or higher is considered 
clinically significant and should raise the clinician’s index of suspicion that the individual 
has a SUD problem or disorder (Ewing, 1984).  
CAGE-AID Screen Scoring (number of YES answers): 
0–1: No risk. Reinforce healthy decisions. 
1–2: Possible risky use: Advise. Patient education. Motivational conversation. 
2–3: Risky Use: Motivational conversation, BI. 
3–4: Possible dependence: Warm handoff to on-site behavioral health specialist 
for assessment, brief treatment, possible referral to substance use treatment. 
Due to language barriers, individual interpretation of the questions, or other 
confounding factors, individuals answering “no” to all CAGE-AID questions may still be 
at risk due to elevated drinking or drug use levels. The CAGE-AID has been validated as 
four-item self-report and parent-report versions as a screen for substance use disorders 
among adolescents in mental health care (Couwenbergh et al., 2009). The Heart Failure 
Program’s SBIRT assessment component used the American Society of Addiction 
Medicine (ASAM) Criteria. The HF program used the ASAM Criteria as their 
multidimensional assessment as a guideline for treatment and referral to a higher level of 
care. This assessment provides insight into how treatment might affect multiple life areas 




assessment is helpful in providing patients with more advanced treatment for possible 
dependence, and if necessary, the patient is referred to a higher level of care.  
The ASAM’s criteria resulted from a collaboration that began in the 1980s to 
define one national set of criteria for providing outcome-oriented and results-based care 
in the treatment of addiction (Mee-Lee, 2013). The ASAM criteria is the most widely 
used and comprehensive set of guidelines for placement, continued stay, and 
transfer/discharge of patients with addiction and co-occurring conditions (Mee-Lee, 
2013). ASAM’s criteria are required in over 30 states. ASAM’s criteria is an 
indispensable resource that addiction medicine professionals rely on to provide a 
nomenclature for describing the continuum of addiction services (Mee-Lee, 2013).  
The ASAM criteria are based on six dimensions:  
Assessment Dimension 1: Acute Intoxication and Withdrawal Potential is the 
assessment for intoxication and withdrawal management. Detoxification in a 
variety of levels of care and preparation for continued addiction services.  
Assessment Dimension 2: Biomedical Conditions and Complications is the 
assessment and treatment of co-occurring physical health conditions or 
complications. Treatment provided within the level of care or through 
coordination of physical health services. 
Assessment Dimension 3: Emotional, Behavioral, or Cognitive Conditions and 
Complications is the assessment and treatment of co-occurring diagnostic or sub-
diagnostic mental health conditions or complications. Treatment provided within 




Assessment Dimension 4: Readiness to Change is the assessment of the stage of 
readiness to change. If not ready to commit to full recovery, engage in treatment 
using motivational enhancement strategies. If ready for recovery, consolidate, and 
expand action for change. 
Assessment Dimension 5: Relapse, Continued Use, or Continued Problem 
Potential is the assessment of readiness for relapse prevention services. 
Assessment Dimension 6: Recovery Environment is the assessment for the need 
for specific individualized family or significant other, housing, financial, 
vocational, educational, legal, transportation, childcare services.  








The Six Dimensions of Multidimensional Assessment From the ASAM by Mee-Lee (2013) 
Dimension Sample question 
1 • Are there current signs of withdrawal? 
• Has the patient been using multiple substances in the same 
drug class? 
2 • Are there current physical illnesses other than withdrawal, that 
need to be addressed or which complicate treatment? 
• Are there chronic conditions which might interfere with 
treatment (e.g., chronic pain with narcotic analgesics)?  
3 • Do any emotional/behavioral problems appear to be an 
expected part of addiction illness or do they appear to be 
separate?  
• Is the patient suicidal, and if so, what is the lethality? 
4 • Does the patient feel coerced into treatment or actively object 
to receiving treatment? 
• If willing to accept treatment, how strongly does the patient 
disagree with others’ perception that s/he has an addiction 
problem? 
5 • How aware is the patient of relapse triggers, ways to cope with 
cravings, and skills to control impulses to use? 
• What is the patient’s level of current craving and how 
successfully can they resist using? 
• Is the patient in immediate danger of continued severe distress 
and drinking/drugging or other high-risk behavior due to co-
occurring mental health problems? 
6 • Are there any dangerous family, significant others, living, 
school, or working situations threatening treatment 
engagement and success?  
• Are there barriers to access to treatment such as transportation 
or childcare responsibilities? 
 
The HF Program’s SBIRT BI component used the Brief Negotiated Interview 
(BNI) as a guideline for their BI. BNI is a short counseling session that is completed 
following the screening, and that incorporates brief feedback and advice with 




related behaviors. The BNI procedure is patient centered, and the skills used are based on 
the patient’s motivation and readiness to change. The BNI used in this study was first 
developed in 1994 by Edward Bernstein, Judith Bernstein and Gail D’Onofrio in 
consultation with Project ASSERT in the emergency room (Bernstein et al., 1997). 
Each step has critical components, specific objectives, and actions. The following 
are the four steps of the BNI: (a) Raise the Subject Comfort; (b) Provide Feedback; (c) 
Enhance Motivation; and (d) Negotiate and Advise. The primary outcome of the BNI 
procedure is the patient’s agreement to reduce alcohol/drug amounts or accept a referral 
to a formal specialized treatment center to decrease harm (medical problems or trauma) 
(Bernstein et al., 1997). It was evident in the literature that BI for alcohol problems are 
effective in a variety of settings including primary care and inpatient trauma settings 
(D’Onofrio & Degutis, 2002; Fleming et al., 1997; Gentilello et al., 1999). 
The brief negotiated interview was a dichotomous independent variable based on 
the value if the patient received a BNI (Yes or No). This study reviewed patient 
electronic health records to view if the patient received a BI. 
The Brief Negotiated Interview (BNI) is a short counseling session that is done 
following the screening, and that incorporates brief feedback and advice with 
motivational enhancement techniques to assist the patient in changing alcohol and drug-
related behaviors (Bernstein et al., 1997). The BNI session is patient-centered, and the 
skills used are based on the patient’s motivation and readiness to change (Bernstein et al., 
1997). This technique is important because this intervention is designed to motivate 




et al., 1997). BNI is a non-confrontational session that is designed to help improve 
chances that the patient will reduce risky alcohol consumption or discontinue harmful 
drug use (Bernstein et al., 1997). One interviewing technique is known as the FRAMES 
model of intervention (Bernstein et al., 1997). This technique comprises: 
• Giving Feedback regarding drug and alcohol use;  
• Leaving Responsibility for change to the patient; 
• Giving the Advice to make a change; 
• Providing a Menu of options; 
• Using an Empathic conversational style; and 
• Boosting the patient’s Self-efficacy to make a change. 
All patients who met the criteria for more advanced SUD treatment options, if 
necessary, were referred to a higher level of care.  
Data Collection Techniques 
A Valley Medical Center HF Program provided the researcher with a de-
identified data set according to specifications for sample and variables used in this study. 
Santa Clara County has determined that using a completely de-identified data set meets 
the federal criteria for not requiring IRB oversight of human subjects’ research. SCVMC 
provided approval and support for this project and use of the dataset. The first variable 
requested was the CAGE-AID score. The CAGE-AID is a continuous independent 
variable based on numerical value-interval 1–4. The second variable that was requested 




third variable was BI received (SBIRT = 1, no-SBIRT = 0), and the last variable is 
Rehospitalizations within 30, 60, and 90 days (1 = Yes, 0 = No).  
Each variable was entered into SPSS for 375 de-identified patients. SPSS was 
used to analyze de-identified secondary data already collected by the HF team at SPSS 
was used to analyze de-identified secondary data already collected by the HF team at 
SCVMC to understand the theory of intentional behavior change that relates to 
rehospitalizations and the use of SBIRT and severity of methamphetamine use (Hosmer 
et al., 2013).  
Dummy variables were created as a tool that allowed the researcher to represent 
nominal-level independent variables in statistical techniques like regression analysis 
(Laerd Statistics, n.d.). Each dummy variable was coded so that it has the value 1 if a 
case is in that category, and 0 if not. Dummy variables are numerical variables used in 
regression analysis to represent subgroups of the sample in a study (Laerd Statistics, 
n.d.). For this study, gender and ethnicity were transformed into dummy variables whose 
attributes were coded into dichotomous variables. A dummy variable is dichotomous, 
e.g., the variable named “Hispanic” has only two attributes: 1 = Hispanic; 0 = Not 
Hispanic. 
Operationalization Variables Measured  
The statistical logistic regression test allowed for this researcher to compare 
which variables had the most influence comparing SBIRT or the severity of 




when there are two or more independent variables of any type (SBIRT and CAGE-AID 
score) (Hosmer et al., 2013).  
The dependent variable was hospital-readmissions during the one-year study 
period which included multiple inpatient stays within a specified period (30-60-90 days) 
by the same patient (Hersh et al., 2013). 
The two independent variables were SBIRT intervention (categorical) and CAGE-
AID score (continuous). SBIRT interventions: dichotomous independent variable based 
on the value if the patient received SBIRT interventions (SBIRT = 1, no-SBIRT = 0) 
which were conducted with each hospital admission. The CAGE-AID score is a 
continuous independent variable based on numerical value-interval 1–4 which was 
collected with each hospital admission.  
The control and intervening variable is: 
CAGE-AID: is a dichotomous variable based on the value if the patient received a 
screening (CAGE-AID = 1, no-CAGE-AID = 0) upon each hospital admission.  
Data Analysis Plan 
I conducted three bi-variate dependent t-test comparing rehospitalizations for each 
time frame by SBIRT and rehospitalizations by CAGE-AID.  
For a categorical dependent variable when there are two or more independent 
variables of any type (SBIRT and CAGE-AID score), logistic regression is an appropriate 
multivariate procedure. This allowed for a comparison which independent variable had 




conducted for the dependent dichotomous variable for the 30, versus 60, versus 90-day 
rehospitalizations. 
The multivariate analysis strategy I utilized was the regression equation:  
re-hosp = α + β1SBIRT + β2 CAGE-AID + µ 
For this study, I sought to understand the links between rehospitalizations and the 
influence of SBIRT and severity of methamphetamine use with patients who have 
chronic health conditions specifically within patients with HF. I examined the secondary 
data in depth to provide data interpretation for the results from the assumptions tests, the 
results from the “Classification Table,” including sensitivity, specificity, positive 
predictive value and negative predictive value; and the results from the “Variables in the 
Equation” table, including which of the predictor variables were statistically significant 
and what predictions were made based on the use of odds ratios.  
Ethical Considerations 
This study used a secondary data set, therefore posed no risk for any human 
participants. Before any data was collected, I established approval from the International 
Review Board (IRB). A letter of usage of agreement to use data was needed from the 
hospital because patient information was not public record. 
Limitations of the Study 
Quantitative research main purpose is the quantification of the data (Simon, 
2011). Since this study looked at a patient cohort with mild to moderate substance use 
disorder (SUD), it was assumed they had greater motivation for change than those 




study had a scope and limitations that would restrict the research questions that were 
answered. Social economic status, psychosocial issues, access to therapy, access to 
healthcare, which all contributed to the higher incident of health risks were not within the 
scope of this study. I was not looking at the severe chronic relapsing level of SUD 
severity but mild to moderate SUD. 
Furthermore, my sample did not consist of random sampling but rather a census 
study because data was gathered on every member of the population. A threat to internal 
validity was present due to the limited research design. It was not feasible to establish a 
randomized control group due to the nature of this community intervention A randomized 
control group was not feasible to withhold SBIRT or substitute an alternative intervention 
in a randomized control group in a community hospital. The boundaries were set for this 
study to facilitate interpretation of the results and help arrive at meaningful conclusions.  
A limitation to this current study was that the threats to reliability may be 
included the subjective responses to CAGE-AID and participants under reporting the 
severity of their SUD. Another threat could have been that those patients who volunteer 
for treatment might be considered to be more motivated to change than those patients 
who did not participate in treatment and so the sample may have been biased.  
Threats to theory validity may have occurred as well. At the beginning of an 
investigation, the researcher usually has a specific viewpoint or theory that he or she feels 
the data will support (Yardley, 2017). I ensured that I did not force the data to match a 




Summary of Research Design 
The current quantitative study sought to illuminate the issue and the influence of 
SBIRT with mild to moderate use of methamphetamine use and rehospitalization within 
chronic patients with heart failure. This study contributed to social change as it might 
open up discussions about the continued need for research on SBI and the effectiveness 
with SUD. There is a need for a better understanding of the links between illicit drug use 
and heart failure outcomes. There is a need for a better understanding of the influence of 
direct interventions such as screening, assessments, and BI, on these patients’ outcomes 
with chronic health conditions. Therefore, it is necessary to develop tailored interventions 
in specialty clinics. For future researchers, there is a need to collaborate with National 
Institute of Health, National Institute on Drug Abuse or Agency of Healthcare Research 
and Quality to conduct more research on SBIRT approaches for substance use 
interventions for patients with heart failure diagnoses.  
While there is substantial research for the effectiveness of SBIRT in reducing 
unhealthy alcohol use and tobacco use/misuse, the evidence for similar models in 
addressing mild to moderate drug use and chronic health condition still needs to be 
developed. This subject has been underwritten, and this study will promote social change 
as for treatment providers to understand that SBIRT is a general approach and not a 
specific technique. SBIRT needs to be modified for use in various settings and not a one-






Chapter 4: Results 
In Chapter 2, I identified important findings in relation to the challenges in the 
effectiveness of the use of SBIRT for the treatment of mild to moderate 
methamphetamine use disorder particularly with a patient cohort who have been 
hospitalized for cardiac complications either caused by or exacerbated by continued 
methamphetamine abuse (Saitz, 2014). The purpose of this quantitative study using an 
existing dataset is to test the theory of intentional behavior change that relates to 
rehospitalizations based on severity of methamphetamine abuse using the CAGE-AID 
score and receiving a SBIRT in the HF Program at Santa Clara County Valley hospital.  
In Chapter 4, I describe data collection, sample demographic characteristics, tests 
of the assumptions, and results of the analysis with tables to demonstrate the data and 
analysis. The demonstration of a statistically significant difference or lack of statistically 
significant differences between these groups was determined with each B tested by the 
Wald chi-square—testing the null that the B coefficient = 0 (the alternate hypothesis is 
that it does not = 0). p values lower than alpha are significant, leading to the rejection of 
the null. The analysis can be used to inform practice with the TTM process of intentional 
behavioral change theory and can help a patient achieve goals of reduction or elimination 
of substance use in the change process (Kennedy & Gregoire, 2009).  
Data Collection 
I extracted data from all hospitalized patients at a SCVMC HF Program with a 
primary discharge diagnosis of HF in the calendar year of 2013. As described in Chapter 




diagnosis of HF. These hospitalizations also comprised of patients with a LVEF ≤ 40%, 
which were categorized into systolic HF. Patients were excluded if they were categorized 
with diastolic dysfunctions only, unable to care for self, has no reliable caregiver, or 
residing in a SNF. Patients were also excluded if enrolled in palliative care/hospice, 
pending cardiac surgery, or end-stage renal disease. This study focused on the 375 
patients who screened positive from a urine toxicology screen for substances from the 
total of 608 patients with HF in the year 2013. This sample did not consist of random 
sampling but rather a census study because data was gathered on every member of this 
population. Exclusion criteria are patients who did not test positive for substance use and 
were not referred for SBIRT. 
Sample Demographic Characteristics 
I analyzed clinical data, which I collected from the HF Program participants at 
SCVMC. I deidentified the data in accordance with the Substance Use Treatment 
Services Department. As the data are not identifiable, there was no way to follow up with 
the participants. To deidentify the data, I removed all names and identifying information 
associated with the data. There is no key to reidentify the data or link it to any identifying 
information.  
Table 2 shows the frequency count and percent of total count of male and female. 
There were a total of 375 participants included in this study: 100 females (26.7%) and 
275 males (73.3%). The largest ethnicity was Caucasian at 132 participants (35.2%), 
followed by Asian at 112 (29.9%), Hispanic at 109 (29.1%), and African American at 22 




and 311 received a CAGE-AID (82.9%). There were a total of 375 CAGE-AID scores 
included in this study; the highest score is two with a total of 115 (30.7%). The mean 
CAGE-AID score is 1.82 and the standard deviation is 1.20. There was a total of 74 








Frequency: Gender, Ethnicity, CAGE-AID, CAGE-AID Score, and Brief Intervention 
 Frequency 
 
Percentage of total 
 
Gender   
Female 100 26.7% 
Male 275 73.3% 
Total 375 100% 
Ethnicity   
Hispanic 109 29.1% 
Caucasian 132 35.2% 
Asian 112 29.9% 
African Am 22 5.9% 




Does not have 
CAGE-AID 
64 17.1% 
Has CAGE-AID 311 82.9% 
Total 375 100 
CAGE-AID Score   
0 66 17.6% 
1 80 21.3% 
2 115 30.7% 
3 82 21.9% 
4 32 8.5% 
Total 375 100% 
 
Table 3 shows the frequency count and percentage of total for patients 
rehospitalized/not hospitalized within 30 days. There were a total of 375 participants 
included in this study; 185 participants did not experience a 30-day rehospitalization 
(49.3%) and 190 participants experienced a 30-day rehospitalization (50.7%). There was 
a total of 209 who participants did not experience a 60-day rehospitalization (55.7%) and 




of 203 participants who did not experience a 90-day rehospitalization (54.1%) and 171 
participants who experienced a 90-day rehospitalization (45.6%). 
Table 3 
 
Frequency: 30-Day Rehospitalization, 60-Day Rehospitalization, and 90-Day 
Rehospitalization 
 Frequency Percentage total 
30-Day   
Rehospitalized 
  
Did not get  
Rehospitalized 
185 49.3% 
Did get  
Rehospitalized 
190 50.7% 




Did not get  
Rehospitalized 
209 55.7% 
Did get  
Rehospitalized 
166 44.3% 




Did not get  
Rehospitalized 
203 54.4% 
Did get  
Rehospitalized 
171 45.6% 






Table 4 shows the comparison of the two groups on key variables. 
Table 4 
 










Chi-square p value 
Gender   3.381 .066 
Female 24.6% 35.1%   
Male 75.4% 64.9%   
Ethnicity     
Hispanic 29.6% 27% 3.525 .317 
Caucasian 34.2% 39.2%   
Asian 31.2% 24.3%   
African Am 5% 9.5%   
CAGE-AID 
Screening 
    
Does not have 
CAGE-AID 
0.3% 85.1% 301.794 .000 
Has CAGE-AID 99.7% 14.9%   
30-Day  
Rehospitalized 
    
Did not get  
Rehospitalized 
56.8% 18.9% 34.119 .000 
Did get  
Rehospitalized 





Did not get  
Rehospitalized 
58% 45.9% 3.580 .058 
Did get  
Rehospitalized 
41.9% 54.1%   
90-Day  
Rehospitalized 
    




Did get  
Rehospitalized 





Researcher requested a Valley Medical Center HF Program provide the researcher 
with a deidentified data set according to specifications for sample size of 375 Patients 
with heart failure who were referred for SBIRT and screen positive for substance use. 
Variables requested were CAGE-AID score, CAGE-AID received, BI received, 
rehospitalized within 30, 60, and 90 days.  
The sample did not consist of random sampling but rather a census study because 
data was gathered on every member of the population. A threat to internal validity is 
present due to the limited research design. It was not feasible to establish a randomized 
control group due to the nature of this community intervention. A randomized control 
group would not have been feasible to withhold SBIRT or substitute an alternative 
intervention in a randomized control group in a community hospital.  
Results 
Process  
SCVMC provided approval and support for this project and use of the dataset. 
The first variable requested was the CAGE-AID score. The CAGE-AID is a continuous 
independent variable based on numerical value-interval 1–4. The second variable that 
was requested was the CAGE-AID received (CAGE-AID received = 1, no CAGE-ID 
received = 0). The third variable was BI received (SBIRT = 1, no-SBIRT = 0), and the 
last variable is Rehospitalizations within 30, 60, and 90 days (1 = Yes, 0 = No). Each 
variable was entered into SPSS for 375 de-identified patients. SPSS was used to analyze 




I created dummy variables as a tool that allowed me to represent nominal-level 
independent variables in statistical techniques like regression analysis (Laerd Statistics, 
n.d.). I coded each dummy variable so that it has the value 1 if a case is in that category, 
and 0 if not.  
Assumptions 
To conduct a logistic regression test, the following assumptions need to be held. 
The first assumption is that the dependent variable is binary. The dependent variable 
(rehospitalization Yes/No) for this study is dichotomous and therefore satisfies this 
assumption. The second assumption requires the observations to be independent of each 
other. This assumption is satisfied because data does not come from matched data or 
repeated measures. The third assumption that needs to be satisfied is that there must be 
little to no multicollinearity in the data. The test for multicollinearity is discussed below. 
This assumption is satisfied because the independent variables are independent from each 
other. The fourth assumption assumes linearity of independent variables, and this 
assumption is true because the independent variables are linearly related to the log odds. 
Finally, logistic regression requires a large sample size. This assumption is satisfied 
because this sample size is large enough. For this project, with a sample size of 375, an 
alpha of .05, an anticipated multi-variate model R2 of 0.1, and an anticipated odds ratio 
(effect size) of 1.50 for the “group assignment” variable (SBIRT versus no SBIRT), the 
expected power to find statistical significance is 0.96, as calculated using GPower 3.1 





One research question was addressed with the statistical logistic regression test. 
The statistical logistic regression test compared which variables had the most influence 
comparing SBIRT (BI) or the severity of methamphetamine use on rehospitalizations. 
Logistic regression was most suitable for a dichotomous dependent variable, when there 
are two or more independent variables of any type (SBIRT and CAGE-AID score) 
(Hosmer et al., 2013).  
The dependent variable is hospital-readmissions during the one-year study period. 
Multiple inpatient stays within a specified period (30, 60, and 90 days) by the same 
patient (Hersh et al., 2013). 
The two independent variables are SBIRT intervention (categorical) and CAGE-
AID score (continuous). SBIRT interventions: dichotomous independent variable based 
on the value if the patient received SBIRT interventions (SBIRT = 1, no-SBIRT = 0) 
which were conducted with each hospital admission. The CAGE-AID score is a 
continuous independent variable, based on numerical value-interval 1–4, which was 
collected with each hospital admission.  
The control and intervening variables are: 
CAGE-AID: is a dichotomous variable based on the value if the patient received a 
screening (CAGE-AID = 1, no-CAGE-AID = 0) upon each hospital admission.  
To begin the test, I formulated the null and alternate hypothesis. The following 




H01: There is no relationship between the dependent variable (rehospitalization) 
when compared to the independent variables. (SBIRT) 
H11: There is a relationship between the dependent variable (rehospitalization) 
when compared to the independent variables. (SBIRT) 
H01: There is no relationship between the dependent variable (rehospitalization) 
when compared to the independent variables. (CAGE-AID Score) 
H11: There is a relationship between the dependent variable (rehospitalization) 
when compared to the independent variables. (CAGE-AID Score) 
The Hosmer and Lemeshow Test was used to determine if the model is sufficient 
by testing the Null hypothesis that the probability of rehospitalization is no different than 
that predicted by the models. Three bi-variate dependent t-test were conducted to 
compare rehospitalizations for each time frame (30, 60, and 90 days) by SBIRT and 
rehospitalizations (30, 60, and 90 days) by CAGE-AID was completed. The Variance 
Inflation Factor (VIF) is a measure of multicollinearity, or correlation 
between independent variables. The VIF diagnostic test is available in SPSS for linear 
regression, but not logistic regression. In order to assess this with SPSS, the logistic 
regression model was run as a linear regression, only specifying the output for 
collinearity diagnostics. This was done iteratively, substituting each independent variable 
as the dependent variable. A VIF score above five is considered to be high collinearity 
(Montgomery et al., 2014). There were no VIF scores higher than 1.30 in any of these 
diagnostic tests. Finally, which included three separate regressions for the dependent 





Research Question 1 asked: Does the SBIRT intervention increase the patient’s 
ability to make a behavioral change and therefore make a difference in rehospitalizations 
for patients with heart failure who screen positive for methamphetamine use? 
In Table 5 from the output crosstabulation, it is demonstrated that there is 19.7% 
of heart failure clients that did not receive SBIRT while 80% received SBIRT equally 
accumulative of 100% for both. I then conducted the Chi-Square to determine if there is a 
relationship between these two variables; this test is statistically significant (X2 = 34.12, p 
< .001). Based on the Chi-Square test, the null hypothesis can be rejected, meaning there 
is a relationship between 30-day rehospitalizations and receiving SBIRT.  
Table 5 
 














   
Rehospitalized 60 130 
 81.1% 43.2% 
   
Total 74 301 
 100% 100% 






The steps were repeated to test the second Null Hypothesis. 
H01: There is no relationship between the dependent variable (rehospitalization) 
when compared to the independent variables (CAGE-AID Score). There are 375 valid 
cases in this study. In Table 6 from the output crosstabulation, I demonstrated that 17.1% 
of HF clients did not receive a CAGE-AID screen while 82.9 % received CAGE-AID 
screening equally accumulative of 100% for both. I then conducted the Chi-Square to 
determine if there is a relationship between these two variables; this test is statistically 
significant (X2 = 28.89, p < .001). Based on the Chi-Square test, the null hypothesis can 
be rejected, meaning there is a relationship between 30-day rehospitalizations and 
receiving CAGE-AID screen.  
Table 6 
 
















   
Rehospitalized 52 138 
 27.4% 72.6% 
     
Total 64 311 
 100% 100% 
 
Once a statistically significant difference was determined with the Chi-Square 




CAGE-AID, the multivariate analysis logistic regression was utilized. Table 7 shows the 
independent variable coefficients and related statistics. Even though it was statistically 
significant, the odds ratio impact for BI is low (Exp (B) = .039, p = .002), however, the 
influence of CAGE-AID Score has a five-fold increase in the likelihood of being 
rehospitalized within 30 days (Exp (B) = 5.144, p = .000). 
Table 7 
 
Influence of Independent Variables on 30-day Rehospitalization with sample size 375 
 B S.E. Exp (B) P Value  
Brief Intervention -3.237 1.060 .039 .002 
CAGE-AID Score 1.638 .195 5.144 .000 
Female -.269  .325 .764 .408 
Hispanic* -.405 .362 .667 .263 
Asian or not* -.089 .350 .915 .799 
African American* -.903 .738 .406 .221 
Age -.010 .013 .990 .455 
Constant -.003 1.209 .997 .998 
*Caucasian is the baseline category 
 
60-day Hospitalizations 
Research Question 1 asked: Does the SBIRT intervention increase the patient’s 
ability to make a behavioral change and therefore make a difference in rehospitalizations 
for patients with heart failure who screen positive for methamphetamine use? 
In Table 8 from the output crosstabulation, it is demonstrated that there is 19.7% 
of HF clients that did not receive SBIRT while 80.3% received SBIRT equally 
accumulative of 100% for both. I then conducted the Chi-Square to determine if there is a 




3.58, p < .058). Based on the Chi-Square test, the null hypothesis can be accepted, 
meaning there is no relationship between 60-day rehospitalizations and receiving SBIRT.  
Table 8 
 














   
Rehospitalized 40 126 
 24.1% 75.9% 
     
Total 74 301 
 100% 100% 
     
 
The steps were repeated to test the second Null Hypothesis. 
H01: There is no relationship between the dependent variable (rehospitalization) 
when compared to the independent variables (CAGE-AID Score). In Table 9 from the 
output crosstabulation, I demonstrated that 13.9% of HF clients did not receive a CAGE-
AID screen while 86.1 % received CAGE-AID screening equally accumulative of 100% 
for both. I then conducted the Chi-Square to determine if there is a relationship between 
these two variables; this test is not statistically significant (X2 = 3.40, p < .065). Based on 
the Chi-Square test, the null hypothesis can be accepted, meaning there is a no 






60-Day Rehospitalization and CAGE-AID Screen Crosstabulation 
 













   
Rehospitalized 35 131 
 21.1% 78.9% 
     
Total 64 311 
 100% 100% 
 
Once a statistically significant difference was not determined with the Chi-Square 
tests for the dependent variable of rehospitalization and SBIRT and rehospitalization by 
CAGE-AID, the multivariate analysis logistic regression was still utilized. Table 10 
shows the independent variable coefficients and related statistics. Although the influence 
of having a BI is not statistically significant (Exp (B) = .497, p = .277), controlling for all 








Influence of Independent Variables on 60-day Rehospitalization with sample size 375 
 B S.E. Exp (B) P Value  
Brief Intervention -.698 .643 0.497 .277 
CAGE-AID Score .363 .125 1.438 .004 
Female  -.119  .273 .888 .664 
Hispanic* -.006 .295 1.006 .983 
Asian* -.158 .292 .854 .590 
African American* -.335 .547 1.398 .540 
Age -.024 .011 1.024 .030 
Constant -1.576 .886 .207 .075 
*Caucasian is the baseline category 
 
90-day Hospitalizations 
Research Question 1 asked: Does the SBIRT intervention increase the patient’s 
ability to make a behavioral change and therefore make a difference in rehospitalizations 
for patients with heart failure who screen positive for methamphetamine use? 
From the output crosstabulation in Table 11, it is demonstrated that 19.8% of HF 
clients did not receive SBIRT while 80.2% received SBIRT equally accumulative of 
100% for both. I then conducted the Chi-Square to determine if there is a relationship 
between these two variables; this test is statistically significant (X2 = 5.70, p < .017). 
Based on the Chi-Square test, the null hypothesis can be rejected, meaning there is a 





















    
Rehospitalized  43 129 
  25.1% 74.9% 
      
Total  74 301 
  100% 100% 
      
 
The steps were repeated to test the second Null Hypothesis. 
H01: There is no relationship between the dependent variable (rehospitalization) 
when compared to the independent variables (CAGE-AID Score). There are 375 valid 
cases in this study. In Table 12 from the output crosstabulation, I demonstrated that 
17.1% of HF clients did not receive a CAGE-AID screen while 82.9% received CAGE-
AID screening equally accumulative of 100% for both. I then conducted the Chi-Square 
to determine a relationship between these two variables; this test is not statistically 
significant (X2 = 2.50, p < .114). Based on the Chi-Square test, I can accept the null 
hypothesis, meaning there is no relationship between 90-day rehospitalizations and 






















   
Rehospitalized 36 136 
 21.1% 78.9% 
     
Total 65 310 
 100% 100% 
     
 
Once a statistically significant relationship was determined with the Chi-Square 
tests for the dependent variable of rehospitalization and SBIRT and not determined for 
rehospitalization by CAGE-AID, the multivariate analysis logistic regression was still 
utilized. Table 13 shows the independent variable coefficients and related statistics. There 
is statistically significant influence for BI (Exp (B) = .218, p = .034); the influence for 
those who do not receive an SBIRT have a 22% higher chance of hospitalization within 








Influence of Independent Variables on 90-day Rehospitalization with sample size 375 
 B S.E. Exp (B) P Value  
Brief Intervention -1.523 .717 .218 .034 
CAGE-AID Score .380 .127 1.462 .003 
Female .057 .275 1.059 .836 
Hispanic* .017 .299 1.017 .955 
Asian* .085 .293 1.088 .772 
African American* .052 .559 1.053 .926 
Age .031 .011 1.031 .005 
Constant -1.213 .930 .297 .192 
*Caucasian is the baseline category 
 
Summary of Results 
This was a quantitative, quasi-experimental, post-test only design with an 
observational comparison group study. The sample included the use of an existing 
dataset. Bivariate and multivariate analyses were conducted to test hypotheses about the 
influence of SBIRT and the severity of methamphetamine use on rehospitalizations over 
30-, 60-, and 90-day periods. 
Table 14 
 
Summary of Multi-Variate Findings 
Rehospitalization SBIRT CAGE-AID Score 
30-day Statistically significant, 
but low influence 
Statistically significant and high 
influence 
60-day Not statistically 
significant 
Statistically significant and high 
influence 
90-day Statistically significant 
and moderate influence 






The statistical logistic regression test compared which variables had the most 
influence comparing SBIRT or the severity of methamphetamine use on 
rehospitalizations. The CAGE-AID Score was statistically significant with 30-, 60-, and 
90-day rehospitalization while controlling for all other variables. In Chapter 5, I discuss 
interpretations of the findings, limitations of the study, recommendations going forward, 






Chapter 5: Discussion, Conclusion, and Recommendations 
The purpose of this quantitative study using an existing dataset is to test the 
theory of intentional behavior change that relates to rehospitalizations. In my analysis for 
this study, I have showed that there were statistically significant relationships between 
SBIRT on 30 and 90 days, but it was a small effect and no effect at all on 60 days. The 
CAGE score had a significant and sizeable effect in all 30, 60, and 90 days analyses. 
Chapter 5 includes an interpretation of the findings, discussion of the theoretical 
framework and the findings, limitations, recommendations going forward, and 
implications for social change. 
Interpretation of Findings 
Research Questions 
The research question for the study is restated in this section with the significance 
levels for each hypothesis: Does the SBIRT intervention increase the patient’s ability to 
make a behavioral change and therefore make a difference in rehospitalizations for 
patients with heart failure who screen positive for methamphetamine use? 
Based upon chi-square tests, the data suggested that the test is significant at the 
0.01 level and well below the common 0.005 threshold. Based on the Chi-square test, I 
can rejected the null hypothesis, meaning that there is a relationship between 30-day 
rehospitalizations and receiving SBIRT and CAGE-AID screen. Multivariate logistic 
regression confirmed the Chi-square test. Controlling for gender, ethnicity, and age for a 




.039, p = .002), the influence of CAGE-AID Score has a five-fold increase in the 
likelihood of being rehospitalized (Exp (B) = 5.144, p = .000). 
At 60-day rehospitalization days the statistically significance effect for having a 
BI is low (Exp (B) = .497, p = .277), controlling for all other variables, there is still an ss 
of the CAGE-AID score on 60-day rehospitalizations. 
At the 90-day rehospitalization there is statistically significant effect for having a 
BI (Exp (B) = .218, p = .034), the effect for those who do not receive an SBIRT have a 
22% higher chance of hospitalization within 90 days. Controlling for all other variables, 
there is still an effect of SBIRT and CAGE-AID score on 90-day rehospitalizations. 
The findings from the multivariate logistic regression confirmed the chi-square 
test. Controlling for age, ethnicity, and gender, rehospitalization was more than five times 
more likely to occur based on the influence of CAGE-AID score. The data presented in 
this study suggest that there was a link between 30-day rehospitalizations and the effect 
of severity of methamphetamine use with patients who have chronic health conditions, 
particularly those who have heart conditions. Based on this study’s findings and what has 
been found in the literature (Chapter 2), this study is important because it contributes to 
the field of physical and behavioral health and promotes an understanding of the 
influence of SBIRT with mild and moderate methamphetamine use disorders and 
comorbid medical conditions. These findings should, however, be examined in light of 




Theoretical Framework and Findings 
During the literature review, the theoretical base for this study was the TTM. The 
TTM began in the 1970s as an attempt to delineate an overarching behavior change 
process (Migneault et al., 2005). The TTM has progressed to view change as occurring 
over time (Prochaska et al., 1992). The TTM provides suggested strategies such as 
SBIRT for public health interventions to address intentional behavior change.  
In the literature review, several studies found that readiness to change was an 
important predictor of response to substance use interventions. More specifically, 
participants who reported greater recognition that their substance use was problematic 
and of the need for change reported larger reductions in their postintervention substance 
use involvement (Bertholet et al., 2009; Carpenter et al., 2002; Collins et al., 2012). The 
review of these studies suggests that people are more inclined to changing their substance 
use if they are aware that a problem exists and recognize the need for change (Bertholet 
et al., 2009; Carpenter et al., 2002; Collins et al., 2012).  
Methamphetamine use is associated with higher rates of a chronic medical 
condition (NIDA, 2013; Stanford, 2009; Yeo et al., 2007). Substance use plays a role in 
the development and exacerbation of chronic medical conditions such as heart failure. 
Therefore, it is important for health care practitioners to detect and address substance use 
in populations with chronic health conditions such as heart failure. After concluding the 
data collection and reviewing the results, it was demonstrated that there is a relationship 
between 30-day rehospitalizations and receiving SBIRT and CAGE-AID screen. The 30-




severity of methamphetamine use based on the CAGE-AID Score has a five-fold increase 
in the likelihood of being rehospitalized. 
When providers do not screen or assess for substance use and misuse, this can 
compromise medical treatment in numerous ways. As the literature found, substance use 
and misuse increase the risks for adverse drug interactions and hampers adherence to 
medications and other treatment protocols (Paratz et al., 2016). Some people do not know 
that their level of substance use is risky. Studies have demonstrated education and 
feedback about the level of use may be enough to motivate change (Tarango & Baird, 
2018). Although the influenc for having a BI was low while controlling for all other 
variables, the findings revealed there was still an influence for patients to be screened 
using the CAGE-AID and CAGE-AID score on 60-day rehospitalizations. 
There has been a significant amount of research that has identified the efficacy of 
the use of screening, BI and referral to treatment (SBIRT) for reducing problem alcohol 
use (SAMSHA, n.d.). Multiple trials of research relating to SBIRT provide evidence of 
SBIRT's effectiveness (Bertholet et al., 2009; Moyer et al., 2002; Whitlock et al., 2004). 
Over the past 5 years, however, a handful of research studies demonstrate the 
effectiveness for reducing illicit drug use among non-treatment-seeking patients (Saitz, 
2014). This study examined the links between the use of screening and use of SBIRT for 
the treatment of mild to moderate methamphetamine use disorder particularly with a 
patient cohort who have been hospitalized for cardiac complications either caused by or 




The research expanded to explore the use of SBIRT for its suitable method of 
identification and intervention techniques for evidence of efficacy in reducing illicit 
substance use (Dwinnells, 2015). Dwinnells’s (2015) quasi-experimental study examined 
the effectiveness of the SBIRT at a community health center. The results suggest that in 
an outpatient clinic, SBIRT is effective in identifying patients at risk for depression, 
alcohol, and substance use. The BI part of SBIRT is a strategy by which people gain 
skills and confidence to help people understand and move through intentional behavioral 
change (DiClemente, 2018).  
The BI that was used in the Heart Failure study, Brief Negotiated Interview, used 
motivational enhancement and cognitive behavioral approaches to help their patients 
address unhealthy thoughts and behaviors associated with current use patterns and 
acquire change. This BI encompasses the many concepts of intentional behavior change 
theory. This study demonstrated at the 90-day rehospitalization there is a statistically 
significant influence for those that did not receive an SBIRT had a 22 percent higher 
chance of hospitalization within 90 days.  
This study demonstrated that an SBIRT intervention increases the 
methamphetamine using patients with heart failure’ ability to make a behavioral change 
and therefore make a difference in rehospitalizations. Despite research indicating low 
efficacy of BI for drug use found through screening in the primary care setting, the results 
showed that participants who received BI had less rehospitalizations over time.  
Finally, as applied to this study, the TTM process of intentional behavioral change 




methamphetamine use and receiving SBIRT. These independent variables influenced the 
dependent variable which is the rehospitalizations. The intentional behavior change can 
help a patient achieve goals of reduction or elimination of compulsive and continued 
substance use in the change process (Kennedy & Gregoire, 2009). TTM was applied to 
the cohort of patients with heart failure who received SBIRT versus those that did not.  
As for the theory of behavior change, using the CAGE score is a proxy for state of 
change since it was not measured directly. In general, the higher the CAGE score 
indicates the lower the readiness to change, the more likely to be rehospitalized, 
underscoring the importance of continuing to use the CAGE or similar screening in HF 
patients. Behavior change is indicated by controlling for CAGE-AID, SBIRT has some 
influence on 30- and 90-day rehospitalization rates. According to the analysis, the CAGE 
score is predictive of rehospitalization; but despite that SBIRT still has an influence, 
though not quite as influential as the CAGE score. The CAGE score odds are higher than 
that of SBIRT. Every point higher in the CAGE score increases the rate of hospitalization 
within 90 days by 46%, whereas having SBIRT avoids rehospitalization by 22%. 
Limitations 
This study looked at a patient cohort with mild to moderate substance use disorder 
(SUD). It was assumed they had greater motivation for change than those patients with a 
severe chronic relapsing level of SUD severity. The current retrospective study had scope 
and limitations that restricted the research questions that were answered. Socioeconomic 




the higher incidence of health risks, were not within the scope of this study. I did not look 
at the severe chronic relapsing level of SUD severity, but mild to moderate SUD. 
Furthermore, my sample from the Santa Clara County hospital may not be 
representative of other geographic regions. The limited research design left the study 
open to several threats to internal validity. It was not feasible to establish a randomized 
control group due to the nature of this community intervention; a randomized control 
group was not feasible to withhold SBIRT or substitute an alternative intervention in a 
randomized control group in a community hospital. The boundaries were set for this 
study to facilitate interpretation of the results and helped to arrive at meaningful 
conclusions.  
A limitation to this current study was that the threats to reliability included the 
subjective responses to CAGE-AID and participants under reporting the severity of their 
SUD. Despite the utility of the CAGE-AID in determining valid responses, there was still 
the possibility of inaccurate self-response. Another threat could have been that those 
patients who volunteered for treatment might be considered to be more motivated to 
change than those patients who did not participate in treatment, and so the sample may 
have been biased. These results, though promising, need further follow-up with a larger 
sample size over time. 
Recommendations 
While there is substantial research for the effectiveness of SBIRT in reducing 
unhealthy alcohol use and tobacco use/misuse, there are few research studies that 




patients (Saitz, 2014). However, this study provides statistical significance in the use of 
SBIRT for the treatment of mild to moderate methamphetamine use disorder, particularly 
with a patient cohort who have been hospitalized for cardiac complications either caused 
by or exacerbated by continued methamphetamine abuse. 
Within the limits of this study, other chronic health conditions treated in primary 
care warrant an exploration for the effectiveness of SBIRT. As such, a recommendation 
to invest in developing a similar study exploring SBIRT-like models for most common 
behavioral health conditions, such as smoking and asthma and alcohol and hypertension, 
for use in public health settings. This would involve research of these comorbidities and 
conducting a comparative study design utilized in this research. 
Implications for Social Change 
Despite this study’s limitations, the influence of CAGE-AID Score having a large 
]]difference with a five-fold increase in the likelihood of being rehospitalized in 30 days 
compared to 60 and 90-day hospitalizations calls for additional research. If under more 
rigorous conditions, the findings can be replicated, then the field of physical and 
behavioral health will have a new and significant evidence-based strategy to support 
substance-using patients with heart failure to recover. This study is unique because it 
addressed an under-researched area for individuals with mild and moderate substance use 
problems with comorbid medical conditions.  
The potential for positive social change is for treatment providers to understand 
that SBIRT is a general approach and not a specific technique. I must modify SBIRT for 




work (Zgierska et al., 2014). The results of this study help health care providers such as 
doctors, nurses, and health educators and social workers to assist in patient substance use 
recovery and coordinate patient discharge and continuity of care following discharge to 
influence the decrease in rehospitalizations (NASW, 2014).  
The potential significance of this research is that it contributed to the existing 
body of SBIRT literature by helping to understand how SBIRT might benefit patients 
with mild to moderate methamphetamine use. It is essential to note that the efficacy of 
SBIRT in reducing or eliminating methamphetamine use has not been investigated and 
addressed with patients with HF. 
Conclusion 
Methamphetamine is one of the most cardiotoxic drugs and can cause numerous 
heart failure problems stemming from chronic drug-induced hypertension, tachycardia, 
and cardiac arrhythmia (Yeo et al., 2007). A diagnostic feature of methamphetamine use 
disorder is continued compulsive use despite adverse medical consequences (DSM-5). 
Even though methamphetamine-associated problems are recognized, there is rarely any 
intervention to reduce methamphetamine use and further complications (Zgierska et al., 
2014). This study has demonstrated that screening and BI—at least for the mild to 
moderate methamphetamine use conditions—results in a statistically significant 
reduction/elimination of continued use and subsequently a reduction in rehospitalizations. 
Despite some limitations, these findings enhance our understanding of the relationship 
between SBIRT and the severity of methamphetamine use on rehospitalizations at 30, 60 
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